RESULT_COUNT: 290,PAGE_SIZE: 10000,CURRENT_PAGE: 1,TOTAL_PAGES: 1,API_CALL_CREDITS: 1
TICKER,FIGI_TICKER,FIGI,TITLE,PUBLICATION_DATE,URL,SUMMARY
AKRX,AKRX:UW,BBG000BBJN38,"Pre-Market Most Active for Oct 18, 2017 :  AUY, GFI, SFUN, EGO, RING, SBGL, IAG, ISBC, UPL, SSRM, PAAS, AKRX",2017-10-18 12:59:14 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/xgoDWXVP7h8/pre-market-most-active-for-oct-18-2017-auy-gfi-sfun-ego-ring-sbgl-iag-isbc-upl-ssrm-paas-akrx-cm861167,The NASDAQ 100 Pre Market Indicator is up 8 35 to 6 130 96 The total Pre Market volume is currently 40 466 987 shares traded The following are the most active stocks for the pre market session Yamana Gold Inc AUY is unchanged at 2 71 with 3 000 000 shares
AKRX,AKRX:UW,BBG000BBJN38,"Akorn, Inc. – Value Analysis (NASDAQ:AKRX) : October 16, 2017",2017-10-16 14:05:11 +0000,http://finance.yahoo.com/r/f779fb1d-39bb-3b7e-896c-816b1580a67c/akorn-inc-value-analysis-nasdaqakrx-october-16-2017?yptr=yahoo&.tsrc=rss,"Categories:  Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives Akorn, Inc. a score of 84. Our analysis is based on comparing Akorn, Inc. with the following peers – Merck & Co., Inc., Valeant Pharmaceuticals International Inc, Pfizer Inc., Johnson & Johnson, Mylan N.V., Teva Pharmaceutical Industries Limited Sponsored ADR, Novartis AG Sponsored ADR, Nissan Chemical Industries, ... Read more
<b>(Read more...)</b>"
AKRX,AKRX:UW,BBG000BBJN38,"Akorn, Inc. breached its 50 day moving average in a Bullish Manner : AKRX-US : October 13, 2017",2017-10-13 12:12:20 +0000,http://finance.yahoo.com/r/e589da13-4627-3c6b-b81c-655ffc40ab5d/akorn-inc-breached-its-50-day-moving-average-in-a-bullish-manner-akrx-us-october-13-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Akorn, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average Bullish 50 ... Read more
<b>(Read more...)</b>"
AKRX,AKRX:UW,BBG000BBJN38,Perrigo Sees IBD RS Rating Improve To 73,2017-10-11 15:16:42 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/wSs683-pALc/perrigo-sees-ibd-rs-rating-improve-to-73-cm858245,Perrigo PRGO had its Relative Strength RS Rating upgraded from 68 to 73 Wednesday a welcome improvement but still below the 80 or higher score you prefer to see ibd display video id 449433 width 50 float left autostart true This exclusive rating
AKRX,AKRX:UW,BBG000BBJN38,See what the IHS Markit Score report has to say about Akorn Inc.,2017-10-09 12:05:10 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120510361.html?.tsrc=rss,"The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices.  Over the last month, growth of ETFs holding AKRX is favorable, with net inflows of $4.45 billion.  This is among the highest net inflows seen over the last one-year and the rate of additional inflows appears to be increasing."
AKRX,AKRX:UW,BBG000BBJN38,"Senvest Management shorting drug stocks Insys, Akorn, Fresenius",2017-10-03 09:16:50 +0000,https://finance.yahoo.com/news/senvest-management-shorting-drug-stocks-091650214.html?.tsrc=rss,"New York-based Senvest Management is shorting three drug stocks, Insys Therapeutics Inc , Akorn Inc and Fresenius SE, its chief executive Richard Mashaal said on Tuesday, Speaking at the Sohn Conference ..."
AKRX,AKRX:UW,BBG000BBJN38,"ETFs with exposure to Akorn, Inc. : September 29, 2017",2017-09-29 14:21:39 +0000,http://finance.yahoo.com/r/e5426fb9-f228-3046-a1b7-2a0248460e4c/etfs-with-exposure-to-akorn-inc-september-29-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Akorn, Inc. Here are 5 ETFs with the largest exposure to AKRX-US. Comparing the performance and risk of Akorn, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more
<b>(Read more...)</b>"
AKRX,AKRX:UW,BBG000BBJN38,See what the IHS Markit Score report has to say about Akorn Inc.,2017-09-29 12:02:48 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120248412.html?.tsrc=rss,"The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices.  Index (PMI) data, output in the Healthcare sector is rising."
AKRX,AKRX:UW,BBG000BBJN38,"Akorn, Inc. breached its 50 day moving average in a Bullish Manner : AKRX-US : September 28, 2017",2017-09-28 12:18:16 +0000,http://finance.yahoo.com/r/bd4b712e-7bf2-3b11-82b4-538c68b8c195/akorn-inc-breached-its-50-day-moving-average-in-a-bullish-manner-akrx-us-september-28-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Akorn, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average Bullish 50 ... Read more
<b>(Read more...)</b>"
AKRX,AKRX:UW,BBG000BBJN38,See what the IHS Markit Score report has to say about Akorn Inc.,2017-09-12 12:02:32 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120232782.html?.tsrc=rss,Akorn Inc NASDAQ/NGS:AKRX
AKRX,AKRX:UW,BBG000BBJN38,"Akorn, Inc. (Nasdaq: AKRX) to Ring The Nasdaq Stock Market Opening Bell",2017-09-07 19:44:16 +0000,https://finance.yahoo.com/news/akorn-inc-nasdaq-akrx-ring-194416670.html?.tsrc=rss,"What: Akorn, Inc., a leading specialty generic pharmaceutical company, will visit the Nasdaq MarketSite in Times Square. In honor of the occasion, Raj Rai, Chief Executive Officer, will ring the Opening ..."
AKRX,AKRX:UW,BBG000BBJN38,See what the IHS Markit Score report has to say about Akorn Inc.,2017-09-06 14:09:36 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-140936573.html?.tsrc=rss,"The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices.  Index (PMI) data, output in the Healthcare sector is rising."
AKRX,AKRX:UW,BBG000BBJN38,See what the IHS Markit Score report has to say about Akorn Inc.,2017-09-05 12:03:43 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120343951.html?.tsrc=rss,"The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices.  Index (PMI) data, output in the Healthcare sector is rising."
AKRX,AKRX:UW,BBG000BBJN38,"ETFs with exposure to Akorn, Inc. : August 28, 2017",2017-08-28 20:42:06 +0000,http://finance.yahoo.com/r/307d2797-0c5c-3924-8a87-2e600ee86b9d/etfs-with-exposure-to-akorn-inc-august-28-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Akorn, Inc. Here are 5 ETFs with the largest exposure to AKRX-US. Comparing the performance and risk of Akorn, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more
<b>(Read more...)</b>"
AKRX,AKRX:UW,BBG000BBJN38,See what the IHS Markit Score report has to say about Akorn Inc.,2017-08-22 12:03:15 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120447496.html?.tsrc=rss,"The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices.  Over the last one-month, outflows of investor capital in ETFs holding AKRX totaled $92 million."
AKRX,AKRX:UW,BBG000BBJN38,Akorn Enters Oversold Territory (AKRX),2017-08-17 17:37:16 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/WG4R0p0_2_g/akorn-enters-oversold-territory-akrx-cm833431,Legendary investor Warren Buffett advises to be fearful when others are greedy and be greedy when others are fearful One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index or RSI which measures momentum on
AKRX,AKRX:UW,BBG000BBJN38,See what the IHS Markit Score report has to say about Akorn Inc.,2017-08-16 12:03:25 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120329929.html?.tsrc=rss,"The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices.  Index (PMI) data, output in the Healthcare sector is rising."
AKRX,AKRX:UW,BBG000BBJN38,"ETFs with exposure to Akorn, Inc. : August 15, 2017",2017-08-15 19:13:24 +0000,http://finance.yahoo.com/r/bb9b5c40-81d1-3a6a-85e5-08fe733701b1/etfs-with-exposure-to-akorn-inc-august-15-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Akorn, Inc. Here are 5 ETFs with the largest exposure to AKRX-US. Comparing the performance and risk of Akorn, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more
<b>(Read more...)</b>"
AKRX,AKRX:UW,BBG000BBJN38,"Magnetar Financial LLC Buys Reynolds American Inc, Level 3 Communications Inc, C.R. ...",2017-08-15 11:34:41 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/m_0hZ8UxcSI/magnetar-financial-llc-buys-reynolds-american-inc-level-3-communications-inc-cr-cm832025,Magnetar Financial LLC New Purchases RAI LVLT AKRX RICE TRCO KATE SWFT DFT STRP KCG Added Positions BCR PNRA ATW ATH WOOF PTEN KMI CMCSA HPE ALR Reduced Positions PAGP RDS B CJ CJ GPOR XEC PXD DVMT RMP EXTN Sold Out
AKRX,AKRX:UW,BBG000BBJN38,See what the IHS Markit Score report has to say about Akorn Inc.,2017-08-14 12:03:36 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120336687.html?.tsrc=rss,"The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices.  Index (PMI) data, output in the Healthcare sector is rising."
AKRX,AKRX:UW,BBG000BBJN38,See what the IHS Markit Score report has to say about Akorn Inc.,2017-08-12 12:04:06 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120406873.html?.tsrc=rss,"The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices.  Over the last one-month, outflows of investor capital in ETFs holding AKRX totaled $47 million."
AKRX,AKRX:UW,BBG000BBJN38,"IHS Markit Score downgrades Akorn Inc to 21 out of 100, ranking positively in only one out of three available IHS Markit categories.",2017-08-11 12:04:04 +0000,https://finance.yahoo.com/news/ihs-markit-score-downgrades-akorn-120404661.html?.tsrc=rss,"The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices.  Over the last one-month, outflows of investor capital in ETFs holding AKRX totaled $47 million."
AKRX,AKRX:UW,BBG000BBJN38,"IHS Markit Score downgrades Akorn Inc to 37 out of 100, ranking positively in only one out of three available IHS Markit categories.",2017-08-10 12:04:58 +0000,https://finance.yahoo.com/news/ihs-markit-score-downgrades-akorn-120458828.html?.tsrc=rss,"The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices.  Index (PMI) data, output in the Healthcare sector is rising."
AKRX,AKRX:UW,BBG000BBJN38,"IHS Markit Score upgrades Akorn Inc to 77 out of 100, despite ranking positively in only one IHS Markit category.",2017-08-09 12:04:58 +0000,https://finance.yahoo.com/news/ihs-markit-score-upgrades-akorn-120458751.html?.tsrc=rss,Akorn Inc NASDAQ/NGS:AKRX
AKRX,AKRX:UW,BBG000BBJN38,"Akorn, Inc. :AKRX-US: Earnings Analysis: Q2, 2017 By the Numbers : August 2, 2017",2017-08-02 19:42:11 +0000,http://finance.yahoo.com/r/e3c01d78-d01d-3882-85af-f4a9641b3dff/akorn-inc-akrx-us-earnings-analysis-q2-2017-by-the-numbers-august-2-2017?yptr=yahoo&.tsrc=rss,"Categories:  Yahoo FinanceGet free summary analysis Akorn, Inc. reports financial results for the quarter ended June 30, 2017. We analyze the earnings along side the following peers of Akorn, Inc. – Merck & Co., Inc., Johnson & Johnson, Novartis AG Sponsored ADR and Abbott Laboratories (MRK-US, JNJ-US, NVS-US and ABT-US) that have also reported for this period. ... Read more
<b>(Read more...)</b>"
AKRX,AKRX:UW,BBG000BBJN38,"Akorn, Inc. breached its 50 day moving average in a Bearish Manner : AKRX-US : August 2, 2017",2017-08-02 13:17:40 +0000,http://finance.yahoo.com/r/5ae3acdc-b5d9-3665-83a6-5e33543ccd0c/akorn-inc-breached-its-50-day-moving-average-in-a-bearish-manner-akrx-us-august-2-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Akorn, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average Bullish 50 ... Read more
<b>(Read more...)</b>"
AKRX,AKRX:UW,BBG000BBJN38,"ETFs with exposure to Akorn, Inc. : August 1, 2017",2017-08-01 20:10:13 +0000,http://finance.yahoo.com/r/267bda41-c0a8-3124-ae72-eb2fa4f54385/etfs-with-exposure-to-akorn-inc-august-1-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Akorn, Inc. Here are 5 ETFs with the largest exposure to AKRX-US. Comparing the performance and risk of Akorn, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more
<b>(Read more...)</b>"
AKRX,AKRX:UW,BBG000BBJN38,Akorn Shareholders Vote to Approve Merger Agreement with Fresenius Kabi,2017-07-19 20:30:00 +0000,https://finance.yahoo.com/news/akorn-shareholders-vote-approve-merger-203000860.html?.tsrc=rss,"LAKE FOREST, Ill., July 19, 2017-- Akorn, Inc., a leading specialty generic pharmaceutical company, announced that its shareholders, at a special meeting held earlier today, have overwhelmingly voted to ..."
AKRX,AKRX:UW,BBG000BBJN38,"ETFs with exposure to Akorn, Inc. : July 13, 2017",2017-07-13 19:25:30 +0000,http://finance.yahoo.com/r/6fab8713-473b-36cd-a248-798b7ddff7db/etfs-with-exposure-to-akorn-inc-july-13-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Akorn, Inc. Here are 5 ETFs with the largest exposure to AKRX-US. Comparing the performance and risk of Akorn, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more
<b>(Read more...)</b>"
AKRX,AKRX:UW,BBG000BBJN38,"SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Akorn, Inc. (AKRX) and Lead Plaintiff Deadline: August 21, 2017",2017-07-11 14:14:00 +0000,https://finance.yahoo.com/news/shareholder-alert-bronstein-gewirtz-grossman-141400156.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / July 11, 2017 / Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed on behalf of common stock shareholders of Akorn, Inc. (""Akorn"" ..."
AKRX,AKRX:UW,BBG000BBJN38,"Johnson & Weaver, Announces Investigations of Omega Protein Corporation, Monogram Residential Trust, Inc. and Akorn, Inc.; Investors Encouraged to Contact Firm",2017-07-08 01:01:00 +0000,https://finance.yahoo.com/news/johnson-weaver-announces-investigations-omega-010100474.html?.tsrc=rss,"Shareholder Rights Law Firm Johnson & Weaver, LLP today announced that it is investigating whether certain officers or directors of Omega Protein Corporation (OME) (""Omega"") violated federal or state laws.  Earlier in 2017, a Securities Class Action Complaint was filed on behalf of those who purchased securities of Omega."
AKRX,AKRX:UW,BBG000BBJN38,"SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Akorn, Inc. (AKRX) and Lead Plaintiff Deadline: August 21, 2017",2017-07-06 14:10:00 +0000,https://finance.yahoo.com/news/shareholder-alert-bronstein-gewirtz-grossman-141000829.html?.tsrc=rss,"NEW YORK , July 6, 2017 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed on behalf of common stock shareholders of ..."
AKRX,AKRX:UW,BBG000BBJN38,"ETFs with exposure to Akorn, Inc. : July 3, 2017",2017-07-03 18:47:57 +0000,http://finance.yahoo.com/r/6861e3eb-1450-3767-ac43-c5f1bb53723a/etfs-with-exposure-to-akorn-inc-july-3-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Akorn, Inc. Here are 5 ETFs with the largest exposure to AKRX-US. Comparing the performance and risk of Akorn, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more
<b>(Read more...)</b>"
AKRX,AKRX:UW,BBG000BBJN38,Top 3 Companies Owned by Valeant (VRX),2017-06-29 14:28:00 +0000,http://finance.yahoo.com/r/a790288d-c230-3579-9522-93c619149d7a/top-3-companies-owned-valeant-vrx.asp?partner=YahooSA&yptr=yahoo&.tsrc=rss,Learn more about Valeant Pharmaceuticals International Inc. and three of the top companies that Valeant owns or operates as subsidiaries.
AKRX,AKRX:UW,BBG000BBJN38,"SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Akorn, Inc. (AKRX)",2017-06-29 14:10:00 +0000,https://finance.yahoo.com/news/shareholder-alert-bronstein-gewirtz-grossman-141000427.html?.tsrc=rss,"NEW YORK, June 29, 2017 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims of whether the board members of Akorn, Inc. (""Akorn"" or the ""Company"") (AKRX) breached their fiduciary duties in connection with the proposed sale of the Company to German based Fresenius Kabi.  Such investors are encouraged to obtain additional information and assist the investigation by visiting the firm's site: www.bgandg.com/akrx.  On April 24, 2017, Akorn revealed that it had signed a definitive merger agreement with Fresenius Kabi, and included in the terms of the agreement, Akorn shareholders will receive $34 in cash for each share of common stock held."
AKRX,AKRX:UW,BBG000BBJN38,"SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Files Class Action Suit Against Akorn, Inc.",2017-06-23 00:00:00 +0000,https://finance.yahoo.com/news/shareholder-alert-rigrodsky-long-p-000000276.html?.tsrc=rss,"WILMINGTON, Del., June 22, 2017-- Rigrodsky & Long, P.A.:. Rigrodsky & Long, P.A. announces that it has filed a class action complaint in the United States District Court for the Middle District of Louisiana ..."
AKRX,AKRX:UW,BBG000BBJN38,The Long Case For Taro Pharmaceutical,2017-06-22 22:20:28 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/vq8cOU9r0MA/the-long-case-for-taro-pharmaceutical-cm807125,By Alessandro Villadei ByAlessandro Villadei Target Price and Rationale Target Price and RationaleTarget Price and Rationale Taro Pharmaceutical TARO is a recommended buy with a price target of 175 Taro Pharmaceutical TARO is a recommended buy with a price target of 175
AKRX,AKRX:UW,BBG000BBJN38,"Noteworthy ETF Outflows: XPH, AKRX, ENDP, PRGO",2017-06-20 16:20:52 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/wBV6J8nwBUM/noteworthy-etf-outflows-xph-akrx-endp-prgo-cm805668,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the SPDR S amp P Pharmaceuticals ETF Symbol XPH where we have detected an approximate 14 7 million dollar outflow that s a 3 3 decrease week over week
AKRX,AKRX:UW,BBG000BBJN38,"ETFs with exposure to Akorn, Inc. : June 19, 2017",2017-06-19 18:52:01 +0000,http://finance.yahoo.com/r/73ea3604-0d72-322c-b573-bbd5980de19c/etfs-with-exposure-to-akorn-inc-june-19-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Akorn, Inc. Here are 5 ETFs with the largest exposure to AKRX-US. Comparing the performance and risk of Akorn, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more
<b>(Read more...)</b>"
AKRX,AKRX:UW,BBG000BBJN38,Top 3 Companies Owned by Valeant (VRX),2017-06-19 13:27:00 +0000,http://finance.yahoo.com/r/a500e6fe-67f0-3af4-939d-5cc0be248dc5/top-3-companies-owned-valeant-vrx.asp?partner=YahooSA&yptr=yahoo&.tsrc=rss,Learn more about Valeant Pharmaceuticals International Inc. and three of the top companies that Valeant owns or operates as subsidiaries.
AKRX,AKRX:UW,BBG000BBJN38,"Akorn, Inc. :AKRX-US: Earnings Analysis: Q1, 2017 By the Numbers : June 16, 2017",2017-06-16 15:45:08 +0000,http://finance.yahoo.com/r/ab5caaab-81f0-335b-9f6c-42774d089fda/akorn-inc-akrx-us-earnings-analysis-q1-2017-by-the-numbers-june-16-2017?yptr=yahoo&.tsrc=rss,"Categories:  Yahoo FinanceGet free summary analysis Akorn, Inc. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of Akorn, Inc. – Merck & Co., Inc., Valeant Pharmaceuticals International Inc, Pfizer Inc., Johnson & Johnson, Mylan N.V., Teva Pharmaceutical Industries Limited Sponsored ADR, Novartis AG Sponsored ADR, Nissan ... Read more
<b>(Read more...)</b>"
AKRX,AKRX:UW,BBG000BBJN38,InPlay from Briefing.com,2017-06-07 14:56:19 +0000,https://finance.yahoo.com/news/inplay-briefing-com-115750752.html?.tsrc=rss,InPlay from Briefing.com
AKRX,AKRX:UW,BBG000BBJN38,"Notable ETF Inflow Detected - PJP, AKRX, BMY, BAX",2017-06-01 16:33:51 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/8_hPny_ZLvY/notable-etf-inflow-detected-pjp-akrx-bmy-bax-cm797496,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the PowerShares Dynamic Pharmaceuticals Portfolio Symbol PJP where we have detected an approximate 93 9 million dollar inflow that s a 12 9 increase week over
AKRX,AKRX:UW,BBG000BBJN38,Top 3 Companies Owned by Valeant (VRX),2017-05-26 14:53:00 +0000,http://finance.yahoo.com/r/dc80498d-b808-3a3e-82ef-54fdeec95eee/top-3-companies-owned-valeant-vrx.asp?partner=YahooSA&yptr=yahoo&.tsrc=rss,Learn more about Valeant Pharmaceuticals International Inc. and three of the top companies that Valeant owns or operates as subsidiaries.
AKRX,AKRX:UW,BBG000BBJN38,"Shareholder Alert: Monteverde & Associates PC Announces An Investigation Of Akorn, Inc. - AKRX",2017-05-23 19:05:00 +0000,https://finance.yahoo.com/news/shareholder-alert-monteverde-associates-pc-190500275.html?.tsrc=rss,"NEW YORK, May 23, 2017 /PRNewswire/ --  Juan Monteverde , founder and managing partner at Monteverde & Associates PC , a boutique securities firm headquartered at the Empire State Building in New York ..."
AKRX,AKRX:UW,BBG000BBJN38,Top 3 Companies Owned by Valeant (VRX),2017-05-09 12:35:00 +0000,http://finance.yahoo.com/r/06bcb618-92e5-34ef-aa2f-0bb0993017b3/top-3-companies-owned-valeant-vrx.asp?partner=YahooSA&yptr=yahoo&.tsrc=rss,Learn more about Valeant Pharmaceuticals International Inc. and three of the top companies that Valeant owns or operates as subsidiaries.
AKRX,AKRX:UW,BBG000BBJN38,"Akorn, Inc. (AKRX), Seaboard Corp (SEB) Lead 10 Notable Investor Filings",2017-05-05 20:28:12 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/xtF2Hl04zUg/akorn-inc-akrx-seaboard-corp-seb-lead-10-notable-investor-filings-cm785291,InvestorPlace Stock Market News Stock Advice amp Trading Tips There were 160 10 notable investor filings today Seaboard Corp NYSEMKT SEB is the largest company of interest When a person or group of persons acquires beneficial ownership of
AKRX,AKRX:UW,BBG000BBJN38,"Fresenius Tops Estimates, Raises Outlook",2017-05-03 07:45:49 +0000,http://finance.yahoo.com/video/fresenius-tops-estimates-raises-outlook-074549491.html?.tsrc=rss,May.03 -- Fresenius CEO Stephan Sturm discusses the company's earnings and performance. He speaks on &quot;Bloomberg Markets.&quot;
AKRX,AKRX:UW,BBG000BBJN38,"SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces an Investigation of Akorn, Inc. -AKRX",2017-05-01 23:05:00 +0000,http://finance.yahoo.com/news/shareholder-alert-brodsky-smith-llc-230500917.html?.tsrc=rss,"BALA CYNWYD, PA / ACCESSWIRE / May 1, 2017 / Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Akorn, Inc. (""Akorn"" or ""the ..."
AKRX,AKRX:UW,BBG000BBJN38,Fresenius Buys Akorn -- What Now?,2017-05-01 17:31:15 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Qg_c9G_wtD0/fresenius-buys-akorn-what-now-cm782179,Dialysis giant Fresenius Medical Care AG NYSE FMS has big expansion plans and part of its strategy relies on bulking up its drug business Recently Fresenius announced it s acquiring Akorn Inc NASDAQ AKRX for 4 3 billion How does this deal help
AKRX,AKRX:UW,BBG000BBJN38,How Trump’s First 100 Days Affected the Healthcare Industry,2017-05-01 17:07:00 +0000,http://finance.yahoo.com/r/29b914ad-353a-3025-be68-270c3361a891/how-trumps-first-100-days-affected-the-healthcare.aspx?yptr=yahoo&.tsrc=rss,Insurers report strong Q1 results despite Obamacare losses; Fresenius plants an Akorn; and Express Scripts&apos; battle with Anthem gets real.
AKRX,AKRX:UW,BBG000BBJN38,Fresenius Buys Akorn -- What Now?,2017-05-01 13:29:00 +0000,http://finance.yahoo.com/r/de944247-c509-3c64-bf8e-a90cfacb8e21/fresenius-buys-akorn-what-now.aspx?yptr=yahoo&.tsrc=rss,A $4.3 billion acquisition provides additional growth opportunity for this European healthcare giant.
AKRX,AKRX:UW,BBG000BBJN38,Merger Buzz Drives Akorn to Top of Health Chart in April,2017-04-30 20:20:00 +0000,http://finance.yahoo.com/r/a80e8877-81cb-3bd4-a974-b156f945e46b/merger-buzz-drives-akorn-to-top-of-health-chart-in-april.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"Other industry list-toppers included MiMedx, Cytokinetics, C.R. Bard, and Spectrum."
AKRX,AKRX:UW,BBG000BBJN38,"INVESTOR ALERT: Brower Piven Commences an Investigation into the Proposed Sale of Akorn, Inc. and Encourages Shareholders to Contact the Firm for Additional Information",2017-04-30 10:00:00 +0000,http://finance.yahoo.com/news/investor-alert-brower-piven-commences-100000493.html?.tsrc=rss,"The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of Akorn, Inc."
AKRX,AKRX:UW,BBG000BBJN38,"Lifshitz & Miller LLP Announces Investigation of AdvancePierre Foods Holdings, Inc., Akorn, Inc., AllianceMMA, Inc., Altisource Portfolio Solutions, DelTaco Restaurants, Inc., Express Scripts Holding Company, China Unicom (Hong Kong) Limited, and Global Eagle Entertainment Inc.",2017-04-28 23:17:00 +0000,http://finance.yahoo.com/news/lifshitz-miller-llp-announces-investigation-231700299.html?.tsrc=rss,"NEW YORK, April 28, 2017 /PRNewswire/ -- AdvancePierre Foods Holdings, Inc. (APFH) Lifshitz & Miller announces investigation into possible breaches of fiduciary duties by the board in connection with the ..."
AKRX,AKRX:UW,BBG000BBJN38,"SHAREHOLDER ALERT: Brower Piven Commences an Investigation into the Proposed Sale of Akorn, Inc. and Encourages Investors to Contact the Firm for Additional Information",2017-04-26 21:28:00 +0000,http://finance.yahoo.com/news/shareholder-alert-brower-piven-commences-212800122.html?.tsrc=rss,"The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of Akorn, Inc."
AKRX,AKRX:UW,BBG000BBJN38,"Akorn, Inc. -- Moody's reviews Akorn's ratings for upgrade",2017-04-26 19:10:09 +0000,http://finance.yahoo.com/r/3237811a-a760-3a2a-8409-024b543c4b20/viewresearchdoc.aspx?docid=PR_365698&WT.mc_id=AM~WWFob29fRmluYW5jZTQyX1NCX0NWX1JhdGluZ19OZXdzX0FsbF9Fbmc=~20170426_PR_365698&yptr=yahoo&.tsrc=rss,"Rating Action: Moody's reviews Akorn's ratings for upgrade. Global Credit Research- 26 Apr 2017. New York, April 26, 2017-- Moody's Investors Serviced placed the ratings of Akorn, Inc. under review for ..."
AKRX,AKRX:UW,BBG000BBJN38,"Fresenius US Finance II, Inc. -- Moody's affirms Fresenius SE's Baa3 issuer rating, outlook stable",2017-04-26 15:30:12 +0000,http://finance.yahoo.com/r/85082fd3-9aef-3875-9b31-604acd9147bc/viewresearchdoc.aspx?docid=PR_365688&WT.mc_id=AM~WWFob29fRmluYW5jZV9TQl9SYXRpbmcgTmV3c19BbGxfRW5n~20170426_PR_365688&yptr=yahoo&.tsrc=rss,"Rating Action: Moody's affirms Fresenius SE's Baa3 issuer rating, outlook stable. Global Credit Research- 26 Apr 2017. Frankfurt am Main, April 26, 2017-- Moody's Investors Service, has today affirmed ..."
AKRX,AKRX:UW,BBG000BBJN38,"Why Mylan, Perrigo and Endo Won't Be Playing Spoiler in Akorn-Fresenius Tie Up",2017-04-25 23:46:00 +0000,http://finance.yahoo.com/r/04fac56d-67c5-3a9d-8126-df24b0a762b9/akorn-is-highly-coveted-but-tea-leaves-don-t-spell-bidding-war.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"Fresenius announced a deal to buy U.S. generic drugmaker Akorn Inc for $4.75 billion, or $34 per share."
AKRX,AKRX:UW,BBG000BBJN38,"AKORN INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Akorn, Inc.",2017-04-25 22:40:00 +0000,http://finance.yahoo.com/news/akorn-investor-alert-former-attorney-224000888.html?.tsrc=rss,"NEW ORLEANS, April 25, 2017 /PRNewswire/ -- Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (""KSF"") are investigating the proposed sale ..."
AKRX,AKRX:UW,BBG000BBJN38,[$$] Fresenius Makes Two Acquisitions to Boost Kabi Clinical Unit,2017-04-25 18:46:02 +0000,http://finance.yahoo.com/r/0d5074a5-6bdf-359a-85a8-fab93a2c059a/fresenius-makes-two-acquisitions-to-boost-kabi-clinical-unit-1493145958?mod=yahoo_hs&yptr=yahoo&.tsrc=rss,German healthcare company Fresenius announced two acquisitions totaling more than $5 billion to strengthen the generic drug business of its clinical nutrition and transfusion operations in the U.S. and ...
AKRX,AKRX:UW,BBG000BBJN38,"Harwood Feffer LLP Announces Investigation of Akorn, Inc.",2017-04-25 16:02:00 +0000,http://finance.yahoo.com/news/harwood-feffer-llp-announces-investigation-160200247.html?.tsrc=rss,"NEW YORK, April 25, 2017 /PRNewswire/ -- Harwood Feffer LLP ( www.hfesq.com ) is investigating potential claims against the board of directors of Akorn, Inc. (""Akorn"" or the ""Company"") ..."
AKRX,AKRX:UW,BBG000BBJN38,"AKORN, INC. SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe Investigates Sale to Fresenius Kabi",2017-04-25 15:38:00 +0000,http://finance.yahoo.com/news/akorn-inc-shareholder-alert-former-153800025.html?.tsrc=rss,"Former United States Securities and Exchange Commission attorney Willie Briscoe is investigating potential claims against the Board of Directors of Akorn, Inc. concerning the sale to Fresenius Kabi."
AKRX,AKRX:UW,BBG000BBJN38,"SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Into Whether the Sale of Akorn, Inc. to Fresenius Kabi for $34 Per Share is Fair to Shareholders - AKRX",2017-04-25 14:38:00 +0000,http://finance.yahoo.com/news/shareholder-alert-levi-korsinsky-llp-143800972.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / April 25, 2017 / The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who purchased Akorn, Inc. (""Akorn"") (NASDAQ: AKRX) stock ..."
AKRX,AKRX:UW,BBG000BBJN38,"Analysts' Actions -- Amazon, C.R. Bard, CyrusOne, Dow and More",2017-04-25 13:03:00 +0000,http://finance.yahoo.com/news/analysts-actions-amazon-c-r-130300658.html?.tsrc=rss,"Here are Tuesday's top research calls, including downgrades for Amazon and C.R. Bard, and new coverage of CyrusOne and Dow Chemical."
AKRX,AKRX:UW,BBG000BBJN38,Fresenius Spends Billions On a Falling Akorn,2017-04-25 13:00:56 +0000,http://finance.yahoo.com/r/b2d973de-0c75-332b-b0ad-ec7cb57f6b16/fresenius-pays-billions-for-a-falling-akorn?utm_source=yahoo&utm_medium=bd&utm_campaign=headline&cmpId=yhoo.headline&yptr=yahoo&.tsrc=rss,Stephan Sturm can't resist a deal.
AKRX,AKRX:UW,BBG000BBJN38,"Pre-Market Most Active for Apr 25, 2017 :  APFH, AKRX, ESRX, ERIC, CATB, STM, KEP, BAC, SAN, CAT, XIV, NFLX",2017-04-25 12:52:50 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/I41hD3YuM8A/pre-market-most-active-for-apr-25-2017-apfh-akrx-esrx-eric-catb-stm-kep-bac-san-cat-xiv-nflx-cm778434,The NASDAQ 100 Pre Market Indicator is up 5 2 to 5 513 23 The total Pre Market volume is currently 19 028 534 shares traded The following are the most active stocks for the pre market session AdvancePierre Foods Holdings Inc APFH is 3 4 at 40 07 with 12 039
AKRX,AKRX:UW,BBG000BBJN38,AKORN (AKRX) ALERT: J&W Launches Investigation into the Sale of Akorn; Is $34 a Fair Price?,2017-04-25 12:03:00 +0000,http://finance.yahoo.com/news/akorn-akrx-alert-j-w-120300789.html?.tsrc=rss,"SAN DIEGO, April 25, 2017 /PRNewswire/ -- Shareholder rights law firm Johnson & Weaver, LLP (J&W) has launched an investigation into whether the board members of Akorn, Inc. (NASDAQ: AKRX) breached their ..."
AKRX,AKRX:UW,BBG000BBJN38,Fresenius and Merck Stocks Top DAX on Biosimilars Deal,2017-04-25 10:01:00 +0000,http://finance.yahoo.com/r/1b7a3433-359a-3f50-af44-5785e7bbf6d0/fresenius-and-merck-stocks-top-dax-on-biosimilars-deal.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,Fresenius announced a deal to buy U.S. generic drugmaker Akorn Inc for $4.75 billion and the biosimilars unit of German peer Merck KGaA.
AKRX,AKRX:UW,BBG000BBJN38,"Fresenius picks up M&A pace with Akorn, Merck KGaA deals",2017-04-25 08:17:16 +0000,http://finance.yahoo.com/news/fresenius-snaps-akorn-merck-kgaas-081535504.html?.tsrc=rss,"German healthcare group Fresenius SE & Co KGaA (FREG.DE) has stepped up its dealmaking, agreeing to buy U.S. generic drugmaker Akorn Inc (AKRX.O) for $4.75 billion (4.37 billion euros) and the biosimilars arm of Germany's Merck KGaA.  Takeovers were part of Fresenius's growth strategy under previous boss Ulf Mark Schneider, now leading Nestle (NESN.S).  The latest deals are in keeping with Fresenius's focus on drugs that have lost patent protection, but also mark a foray into new dosage forms, therapeutic areas and biotech drugs for its Kabi unit, a maker of generic infusion drugs as well as tube feeding and blood transfusion equipment."
AKRX,AKRX:UW,BBG000BBJN38,"Fresenius snaps up Akorn, Merck KGaA's biosimilars in separate deals",2017-04-24 22:33:23 +0000,http://finance.yahoo.com/news/fresenius-snaps-akorn-merck-kgaas-212255907.html?.tsrc=rss,"While in keeping with its focus on drugs that have lost patent protection, the deals mark a foray into new dosage forms, new therapeutic areas and into biotech drugs for Fresenius's Kabi unit, a maker of generic infusion drugs, tube feeding and blood transfusion equipment.  Akorn will add products such as medical creams, ophthalmic drugs, oral liquids, ear drops, nasal sprays and respiratory drugs, where competition is relatively benign when compared with standard pills and tablets.  The deal with Merck, in turn, marks the entry into biosimilar copies of complex biologic drugs made from living cells, which Fresenius has previously shunned."
AKRX,AKRX:UW,BBG000BBJN38,Germany's Fresenius Kabi to buy Akorn for $4.3 billion,2017-04-24 21:13:43 +0000,http://finance.yahoo.com/r/6bd731ef-4b81-3427-9011-121071775630/Story.aspx?guid=A47EEF6B-C4EE-4C5D-972A-0819BEC787AC&siteid=yhoof2&yptr=yahoo&.tsrc=rss,"Germany-based Fresenius Kabi will buy Akorn Inc. for $34 a share, plus the assumption of roughly $450 million of debt, for a deal valued at $4.3 billion, the companies said Monday. The deal is expected ..."
AKRX,AKRX:UW,BBG000BBJN38,Fresenius Buys Akorn for $4.3 Billion in U.S. Expansion,2017-04-24 21:01:44 +0000,http://finance.yahoo.com/r/0010c302-23ee-334d-8a8a-308da33b1fd4/fresenius-agrees-to-buy-akorn-merck-kgaa-biosimilars-business?utm_source=yahoo&utm_medium=bd&utm_campaign=headline&cmpId=yhoo.headline&yptr=yahoo&.tsrc=rss,"In just 10 months at the head of Germany’s Fresenius SE, Chief Executive Officer Stephan Sturm has now inked the health-care provider’s two biggest-ever deals."
AKRX,AKRX:UW,BBG000BBJN38,Fresenius Kabi to Acquire Akorn,2017-04-24 20:58:00 +0000,http://finance.yahoo.com/news/fresenius-kabi-acquire-akorn-205800399.html?.tsrc=rss,"Fresenius Kabi has agreed to acquire Akorn , a U.S.-based manufacturer and marketer of prescription and over-the-counter pharmaceutical products, for approximately $4.3 billion, or $34.00 a share, plus the assumption of approximately $450 million of debt1."
AKRX,AKRX:UW,BBG000BBJN38,Fresenius Kabi To Buy Akorn; To Acquire Merck KGaA's Biosimilars Business,2017-04-24 17:49:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/C9XeocoIIIw/fresenius-kabi-to-buy-akorn-to-acquire-merck-kgaas-biosimilars-business-20170424-01389,Fresenius Kabi To Buy Akorn; To Acquire Merck KGaA's Biosimilars Business
AKRX,AKRX:UW,BBG000BBJN38,Exclusive: Fresenius nears deal to acquire Akorn - sources,2017-04-24 16:45:36 +0000,http://finance.yahoo.com/news/exclusive-fresenius-nears-deal-acquire-164536077.html?.tsrc=rss,"Acquiring Akorn would add around $1 billion in annual sales to Fresenius' drugmaking division, giving it a significantly larger presence in eyecare and other areas widely perceived as  somewhat insulated from generic drug pricing pressure.  The deal values Akorn in the region of $33 to $35 per share, said the sources.  Akorn shares were hovering around $32 on Monday afternoon in New York, up by more than a third since April 7, when it confirmed it was in talks with Fresenius about a potential deal."
AKRX,AKRX:UW,BBG000BBJN38,4 Stocks With Strong Technical Momentum,2017-04-21 12:40:10 +0000,http://finance.yahoo.com/news/4-stocks-strong-technical-momentum-124010541.html?.tsrc=rss,"A number of stocks are looking strong technically this week with the market's upside reversal. Here are four to watch. Akorn, Inc. (NASDAQ: AKRX ) had a strong reversal session on Tuesday, up $1.05 or ..."
AKRX,AKRX:UW,BBG000BBJN38,4 Stocks with Strong Technical Momentum,2017-04-19 17:17:48 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/T0akuu2u2qw/4-stocks-with-strong-technical-momentum-cm775981,"By Harry Boxer   A number of stocks are looking strong technically this week with the market's upside reversal.  Here are four to watch.  Akorn, Inc. ( AKRX ) had a strong reversal session on Tuesday, up $1.05 or 3.28%, to $33.04.  After surging in the second week of April on news of being in talks to be acquired by"
AKRX,AKRX:UW,BBG000BBJN38,"FPA Capital Buys 2 Beaten Down Stocks, Energy in Fourth Quarter",2017-04-12 18:54:22 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-nMxvjAYVjQ/fpa-capital-buys-2-beaten-down-stocks-energy-in-fourth-quarter-cm773450,FPA Capital released its first portfolio update of 2017 disclosing purchase of two new positions and a raft of oil and gas stocks as it adhered to its guideline of selling equities that approach intrinsic value and buying those with a margin of safety and price discount to intrinsic value
AKRX,AKRX:UW,BBG000BBJN38,"Analyst: Akorn Could Be Sold For As Much As $34 Per Share, But There's Double-Digits Downside If Deal Doesn't Happen",2017-04-11 18:47:39 +0000,http://finance.yahoo.com/news/analyst-akorn-could-sold-much-184739779.html?.tsrc=rss,"Last week, Fresenius Kabi, a subsidiary of Fresenius Medical Care AG & Co. (ADR) (NYSE: FMS ) said it was looking into the possibility of acquiring Akorn, Inc. (NASDAQ: AKRX ). Since the announcement, ..."
AKRX,AKRX:UW,BBG000BBJN38,"Akorn, Inc. (AKRX) Stock Soars on Possible Fresenius Deal",2017-04-10 22:54:27 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/2QPdL40v1QU/akorn-inc-akrx-stock-soars-on-possible-fresenius-deal-cm772435,InvestorPlace Stock Market News Stock Advice amp Trading Tips Akorn Inc NASDAQ AKRX shares skyrocketed to kick off the week as the company is being discussed as the subject of a potential buyout Fresenius Medical Care AG amp
AKRX,AKRX:UW,BBG000BBJN38,"Health Care Sector Update for 04/10/2017: AKRX,FMS,CYTX,OMED",2017-04-10 20:33:50 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/mmXUhcvAFns/health-care-sector-update-for-04102017-akrxfmscytxomed-cm772358,Top Health Care StocksTop Health Care Stocks JNJ 0 50 JNJ 0 50 PFE 0 22 PFE 0 22 MRK 0 42 MRK 0 42 ABT 0 84 ABT 0 84 AMGN 0 22 AMGN 0 22 Health care stocks continue to edge lower this afternoon with the NYSE Health Care Index slipping about 0 1 while shares of health care
AKRX,AKRX:UW,BBG000BBJN38,Akorn Acquisition Talks Send Generic Drugmakers Into Orbit,2017-04-10 20:31:17 +0000,http://finance.yahoo.com/r/b2b9fc89-8fa8-3e8e-96a1-fc76a82b43bb/could-this-small-biotech-get-taken-over-by-germanys-fresenius?src=A00220A&yptr=yahoo&.tsrc=rss,"Akorn stock gapped up 10% Monday, after confirmation late Friday that it&apos;s in talks to be acquired by Fresenius Kabi."
AKRX,AKRX:UW,BBG000BBJN38,Here's Why Akorn Inc. Rose as Much as 12.8% Today,2017-04-10 19:55:11 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/fBaXgjYh-mU/heres-why-akorn-inc-rose-as-much-as-128-today-cm772309,What happened Shares of specialty generic pharmaceutical manufacturer Akorn Inc NASDAQ AKRX rose nearly 13 this morning after management announced that it was discussing a possible sale to Fresenius Kabi The potential suitor is a subsidiary of Fresenius SE amp Co KGaA a
AKRX,AKRX:UW,BBG000BBJN38,Here&apos;s Why Akorn Inc. Rose as Much as 12.8% Today,2017-04-10 18:07:00 +0000,http://finance.yahoo.com/r/782873f3-7ad5-3e2b-a7f5-85c51698dab7/heres-why-akorn-inc-rose-as-much-as-128-today.aspx?yptr=yahoo&.tsrc=rss,Management confirmed that it was in buyout talks with Fresenius Kabi for the potential sale of Akorn.
AKRX,AKRX:UW,BBG000BBJN38,Akorn Takeover Talk Unsurprising,2017-04-10 17:00:00 +0000,http://finance.yahoo.com/news/akorn-takeover-talk-unsurprising-170000367.html?.tsrc=rss,"The company is a likely takeover target, thanks to its focus on more complex generic drug products."
AKRX,AKRX:UW,BBG000BBJN38,"Akorn, Inc.: Leads amongst peers with strong fundamentals",2017-04-10 16:18:01 +0000,http://finance.yahoo.com/r/9f17429c-676b-3430-9dc3-7cacba0a3a74/akorn-inc-leads-amongst-peers-with-strong-fundamentals?yptr=yahoo&.tsrc=rss,"Categories:  Yahoo FinanceAkorn, Inc. relative valuation is NEUTRAL and it has a fundamental analysis score of 78. Our analysis is based on comparing Akorn, Inc. with the following peers – Merck & Co., Inc., Valeant Pharmaceuticals International Inc, Pfizer Inc., Johnson & Johnson, Mylan N.V., Teva Pharmaceutical Industries Limited Sponsored ADR, Novartis AG Sponsored ADR, Nissan Chemical ... Read more
<b>(Read more...)</b>"
AKRX,AKRX:UW,BBG000BBJN38,AKRX Crosses Above Average Analyst Target,2017-04-10 14:54:11 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/OmYJuyabJho/akrx-crosses-above-average-analyst-target-cm772055,In recent trading shares of Akorn Inc Symbol AKRX have crossed above the average analyst 12 month target price of 25 90 changing hands for 29 77 share When a stock reaches the target an analyst has set the analyst logically has two ways to react downgrade on valuation or re adjust
AKRX,AKRX:UW,BBG000BBJN38,Stocks Open Higher; Analyst Note Lifts Tesla; Canada Goose Rises,2017-04-10 13:40:40 +0000,http://finance.yahoo.com/r/1349f3c0-621a-3f4f-a301-0e4bfe272321/nasdaq-100-s-tesla-akorn-jump?src=A00220A&yptr=yahoo&.tsrc=rss,U.S. stocks opened higher Monday as a few headlines garnered early interest.
AKRX,AKRX:UW,BBG000BBJN38,The Market In 5 Minutes,2017-04-10 13:15:34 +0000,http://finance.yahoo.com/news/market-5-minutes-131534765.html?.tsrc=rss,IN THE NEWS BENZINGA Your local ATM could recognize your face within five years. Your taxes could be prepared by a robo-accountant. Your lawyer might be reduced to an algorithm fully versed in legal precedent: ...
AKRX,AKRX:UW,BBG000BBJN38,"Pre-Market Most Active for Apr 10, 2017 :  BBL, GERN, AKRX, NVO, BAC, MT, XIV, BHP, CHK, TSLA, QQQ, ASML",2017-04-10 12:53:52 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/QxvMU1KSS-0/pre-market-most-active-for-apr-10-2017-bbl-gern-akrx-nvo-bac-mt-xiv-bhp-chk-tsla-qqq-asml-cm771938,The NASDAQ 100 Pre Market Indicator is up 6 41 to 5 424 78 The total Pre Market volume is currently 3 863 307 shares traded The following are the most active stocks for the pre market session BHP Billiton plc BBL is 1 25 at 33 10 with 486 055 shares traded BBL
AKRX,AKRX:UW,BBG000BBJN38,European Markets Finished Mixed As Geopolitical Concerns Persist,2017-04-10 11:55:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ZVbp623DHuY/european-markets-finished-mixed-as-geopolitical-concerns-persist-20170410-00799,European Markets Finished Mixed As Geopolitical Concerns Persist
AKRX,AKRX:UW,BBG000BBJN38,European Shares Mostly Lower In Cautious Trade; Miners Surge,2017-04-10 05:36:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/dIGvi333q_s/european-shares-mostly-lower-in-cautious-trade-miners-surge-20170410-00154,European Shares Mostly Lower In Cautious Trade; Miners Surge
AKRX,AKRX:UW,BBG000BBJN38,"AKRX Confirms Acquisition Talks, CBIO Plunges, Be All Ears For GERN",2017-04-09 19:30:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/PxysMOkMLBc/akrx-confirms-acquisition-talks-cbio-plunges-be-all-ears-for-gern-20170409-00034,"AKRX Confirms Acquisition Talks, CBIO Plunges, Be All Ears For GERN"
AKRX,AKRX:UW,BBG000BBJN38,[$$] Fresenius in Talks to Buy U.S. Drug Maker Akorn,2017-04-08 11:26:09 +0000,http://finance.yahoo.com/r/a36672b7-634c-327c-b020-9f7b5d668c48/fresenius-in-talks-to-buy-u-s-drug-maker-akorn-1491649906?mod=yahoo_hs&yptr=yahoo&.tsrc=rss,"German health-care company Fresenius is in discussions to acquire U.S. firm Akorn, a maker of generic drugs that is currently valued at about $3.7 billion."
AKRX,AKRX:UW,BBG000BBJN38,Germany's Fresenius Confirms Talks To Buy Generic Drugmaker Akorn,2017-04-08 02:58:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/K_fR9iar8y8/germanys-fresenius-confirms-talks-to-buy-generic-drugmaker-akorn-20170408-00002,Germany's Fresenius Confirms Talks To Buy Generic Drugmaker Akorn
AKRX,AKRX:UW,BBG000BBJN38,Germany's Fresenius in talks to buy generic drugmaker Akorn,2017-04-07 22:12:10 +0000,http://finance.yahoo.com/news/germanys-fresenius-weighing-bid-generic-192907773.html?.tsrc=rss,"Shares of Akorn, which has a market value of about $3.7 billion, were up 10 percent at $32.60 in aftermarket trading.  There can be no assurance any transaction will result from these discussions, Fresenius said in a statement.  Akorn confirmed the talks with Fresenius, whose businesses range from kidney dialysis and tube feeding equipment to running hospitals."
AKRX,AKRX:UW,BBG000BBJN38,Akorn Confirms Discussions with Fresenius Kabi,2017-04-07 21:58:43 +0000,http://finance.yahoo.com/news/akorn-confirms-discussions-fresenius-kabi-215843205.html?.tsrc=rss,"LAKE FOREST, Ill., April 07, 2017-- Akorn, Inc., a leading specialty generic pharmaceutical company, today confirmed that Akorn is currently in discussions with Fresenius Kabi, a subsidiary of Fresenius ..."
AKRX,AKRX:UW,BBG000BBJN38,"Why Diana Shipping, Akorn, and Granite Construction Jumped Today",2017-04-07 21:54:42 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0ESEu4dJnL0/why-diana-shipping-akorn-and-granite-construction-jumped-today-cm771613,The stock market closed on Friday narrowly mixed with major market benchmarks barely budging in either direction as investors tried to navigate through conflicting news items On one hand rising geopolitical risk globally became much more apparent after the U S military launched
AKRX,AKRX:UW,BBG000BBJN38,"Friday's ETF Movers: PJP, OIH",2017-04-07 21:54:37 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ZTf-7owsIZY/fridays-etf-movers-pjp-oih-cm771626,In trading on Friday the PowerShares Dynamic Pharmaceuticals Portfolio ETF PJP is outperforming other ETFs up about 2 4 on the day Components of that ETF showing particular strength include shares of Akorn AKRX up about 18 6 and shares of Depomed DEPO up about 15 4 on
AKRX,AKRX:UW,BBG000BBJN38,"Close Update: Geopolitical Risks, Jobs Report Weigh on Stocks",2017-04-07 21:13:34 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/d8a70vwzGEo/close-update-geopolitical-risks-jobs-report-weigh-on-stocks-cm771618,Weighed down by a disappointing labor market report geopolitical risks and lingering concerns about the Federal Reserve s plans to unwind its 4 5 trillion bond portfolio all three benchmark indices closed lower on Friday after slipping in and out of negative territory throughout the day
AKRX,AKRX:UW,BBG000BBJN38,Akorn Launches To Six-Month High On Fresenius Takeover Rumor,2017-04-07 20:39:15 +0000,http://finance.yahoo.com/r/93940529-6b50-3fa6-8625-73e25d3582b5/akorn-launches-to-six-month-high-on-fresenius-takeover-rumor?src=A00220A&yptr=yahoo&.tsrc=rss,"Akorn Therapeutics stock launched to a six-month high midday Friday, outperforming other generic drugmakers."
AKRX,AKRX:UW,BBG000BBJN38,"Why Diana Shipping, Akorn, and Granite Construction Jumped Today",2017-04-07 20:34:00 +0000,http://finance.yahoo.com/r/4add5e2c-a96b-35bb-8387-b648a194ee0e/why-diana-shipping-akorn-and-granite-construction.aspx?yptr=yahoo&.tsrc=rss,These stocks shot significantly higher on a day when all three major market indexes closed within a tenth of a percent of where they opened.
AKRX,AKRX:UW,BBG000BBJN38,"ETFs with exposure to Akorn, Inc. : April 7, 2017",2017-04-07 19:44:31 +0000,http://finance.yahoo.com/r/768a9a18-521d-30df-9726-e9b63e5f4d5f/etfs-with-exposure-to-akorn-inc-april-7-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Akorn, Inc. Here are 5 ETFs with the largest exposure to AKRX-US. Comparing the performance and risk of Akorn, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more
<b>(Read more...)</b>"
AKRX,AKRX:UW,BBG000BBJN38,Jury awards $20M in Georgia couple case's against drug maker,2017-04-07 19:05:17 +0000,http://finance.yahoo.com/r/aa325536-80ee-3d2e-85b7-e151fd2c7ba7/jury-awards-20m-georgia-couple-190511950.html?.tsrc=rss,"WARNER ROBINS, Ga. (AP) — A Georgia jury has awarded more than $20 million to a retired kindergarten teacher and her husband who claimed that a pharmaceutical company failed to include a warning on a prescription drug label that it would harmfully interact with another drug she was taking."
AKRX,AKRX:UW,BBG000BBJN38,Akorn shares surge 20% on report Germany's Fresenius is mulling a bid,2017-04-07 18:52:42 +0000,http://finance.yahoo.com/r/182a4b09-c7fe-346a-9c92-9093a3e608e2/Story.aspx?guid=47D30160-D664-4400-BC8F-69D3DE4F4407&siteid=yhoof2&yptr=yahoo&.tsrc=rss,"Shares of generic drug company Akorn Inc. rallied 20% Friday, after Bloomberg reported that Germany's Fresenius SE & Co. KGaA is mulling a bid. Bloomberg said the two companies are in talks, but have not ..."
AKRX,AKRX:UW,BBG000BBJN38,Why Valeant Just Popped,2017-04-07 17:41:00 +0000,http://finance.yahoo.com/r/ee2a9898-6ee9-32bf-b0c7-30f0be946ce8/why-valeant-just-popped?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"At 1:00 p.m., Valeant Pharmaceuticals International (VRX) was trading at $9.53. 20 Minutes later it had jumped 2.7% to $9.79. What gives? Credit Akorn (AKRX), which has jumped 13% after Bloomberg reported ..."
AKRX,AKRX:UW,BBG000BBJN38,Fresenius Says It's in Talks to Buy Generic Drugmaker Akorn,2017-04-07 17:04:46 +0000,http://finance.yahoo.com/r/4feaedb9-30e4-3410-8fe5-15ee98f275e5/fresenius-said-to-consider-bid-for-u-s-generic-drugmaker-akorn?utm_source=yahoo&utm_medium=bd&utm_campaign=headline&cmpId=yhoo.headline&yptr=yahoo&.tsrc=rss,"Fresenius SE, Europe’s biggest publicly traded health-care provider, said Friday that it’s in talks to buy U.S. generic drugmaker Akorn Inc."
AKRX,AKRX:UW,BBG000BBJN38,"Monday's ETF Movers: PJP, VOX",2017-03-27 18:59:18 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/h1yKb6bLnl4/mondays-etf-movers-pjp-vox-cm766082,In trading on Monday the PowerShares Dynamic Pharmaceuticals Portfolio ETF PJP is outperforming other ETFs up about 1 7 on the day Components of that ETF showing particular strength include shares of Impax Laboratories IPXL up about 32 2 and shares of Akorn AKRX up about 5
AKRX,AKRX:UW,BBG000BBJN38,Is The Market Expensive? Buffett Says No,2017-03-20 18:55:00 +0000,http://www.forbes.com/sites/investor/2017/03/20/is-the-market-expensive-buffett-says-no/?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix,Is The Market Expensive? Buffett Says No
AKRX,AKRX:UW,BBG000BBJN38,Is The Market Expensive? Buffett Says No,2017-03-20 18:55:00 +0000,http://finance.yahoo.com/r/d2809129-69f7-34ed-b291-d6b73e99cdb3/is-the-market-expensive-buffett-says-no?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix&yptr=yahoo&.tsrc=rss,"According to the Oracle of Omaha, ""we're not in a bubble territory or anything of the sort."""
AKRX,AKRX:UW,BBG000BBJN38,Blog Coverage Mylan Announces Launch of Generic Version of Pfizer's Antidepressant PRISTIQ in US,2017-03-13 12:15:00 +0000,http://finance.yahoo.com/news/blog-coverage-mylan-announces-launch-131500947.html?.tsrc=rss,"Upcoming AWS Coverage on Akorn Post-Earnings Results LONDON, UK / ACCESSWIRE / March 13, 2017 / Active Wall St. blog coverage looks at the headline from Mylan N.V. (NASDAQ: MYL ) as the Company announced ..."
AKRX,AKRX:UW,BBG000BBJN38,Blog Coverage Mylan Announces Launch of Generic Version of Pfizer's Antidepressant PRISTIQ in US,2017-03-13 12:15:00 +0000,http://finance.yahoo.com/news/blog-coverage-mylan-announces-launch-131500947.html,"[Accesswire] - Upcoming AWS Coverage on Akorn Post-Earnings Results LONDON, UK / ACCESSWIRE / March 13, 2017 / Active Wall St. blog coverage looks at the headline from Mylan N.V. (NASDAQ: MYL ) as the Company announced ..."
AKRX,AKRX:UW,BBG000BBJN38,"PJP, AKRX, LGND, MYL: ETF Outflow Alert",2017-03-09 17:14:14 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/cEFuGIuUzyE/pjp-akrx-lgnd-myl-etf-outflow-alert-cm758566,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the PowerShares Dynamic Pharmaceuticals Portfolio Symbol PJP where we have detected an approximate 56 8 million dollar outflow that s a 6 7 decrease week over
AKRX,AKRX:UW,BBG000BBJN38,AKORN INC Financials,2017-03-07 18:04:12 +0000,http://finance.yahoo.com/q/is?s=akrx,AKORN INC Financials
AKRX,AKRX:UW,BBG000BBJN38,Mid-Day Market Update: Dow Falls 80 Points; Concert Pharma Shares Spike Higher,2017-03-06 18:32:59 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/fN5s1tfCBE0/mid-day-market-update-dow-falls-80-points-concert-pharma-shares-spike-higher-cm756798,Midway through trading Monday the Dow traded down 0 41 percent to 20 920 47 while the NASDAQ declined 0 71 percent to 5 829 17 The S amp P also fell dropping 0 60 percent to 2 368 89 Leading and Lagging Sectors Non cyclical consumer goods amp services shares slipped by just 0
AKRX,AKRX:UW,BBG000BBJN38,"ETFs with exposure to Akorn, Inc. : March 6, 2017",2017-03-06 18:27:29 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-akorn-inc-march-6-2017/,"ETFs with exposure to Akorn, Inc. : March 6, 2017"
AKRX,AKRX:UW,BBG000BBJN38,"ETFs with exposure to Akorn, Inc. : March 6, 2017",2017-03-06 18:27:29 +0000,http://finance.yahoo.com/r/1020bd35-5915-31d7-a496-4cfcf97e6c28/etfs-with-exposure-to-akorn-inc-march-6-2017?yptr=yahoo&.tsrc=rss,"Categories:   ETFs Yahoo Finance Click here to see latest analysis ETFs with exposure to Akorn, Inc. Here are 5 ETFs with the largest exposure to AKRX-US. Comparing the performance and risk of Akorn, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more    
<b>(Read more...)</b>"
AKRX,AKRX:UW,BBG000BBJN38,Does Reward Potential Still Outweigh The Risk In Akorn Shares?,2017-03-06 18:25:18 +0000,http://finance.yahoo.com/news/does-reward-potential-still-outweigh-182518211.html,Does Reward Potential Still Outweigh The Risk In Akorn Shares?
AKRX,AKRX:UW,BBG000BBJN38,Does Reward Potential Still Outweigh The Risk In Akorn Shares?,2017-03-06 18:25:18 +0000,http://finance.yahoo.com/news/does-reward-potential-still-outweigh-182518211.html?.tsrc=rss,"Deutsche Bank downgraded Akorn, Inc. (NASDAQ: AKRX ) to Hold from Buy as the stock has recovered since the post-third quarter correction. According to Deutsche Bank, further upside will depend on “hard-to-call ..."
AKRX,AKRX:UW,BBG000BBJN38,New Strong Sell Stocks for March 6th,2017-03-06 17:15:29 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/m0B2MgqW1-E/new-strong-sell-stocks-for-march-6th-cm756662,Here are 5 stocks added to the Zacks Rank 5 Strong Sell List today Akorn Inc AKRX manufactures and markets diagnostic and therapeutic pharmaceuticals The Zacks Consensus Estimate for its current year earnings has been revised 7 6 downward over the last 30 days Compass
AKRX,AKRX:UW,BBG000BBJN38,Bullish and Bearish Reversals in the Market,2017-03-06 17:00:00 +0000,http://realmoney.thestreet.com/articles/03/06/2017/bullish-and-bearish-reversals-market?puc=yahoo&cm_ven=YAHOO,Bullish and Bearish Reversals in the Market
AKRX,AKRX:UW,BBG000BBJN38,Bullish and Bearish Reversals in the Market,2017-03-06 17:00:00 +0000,http://finance.yahoo.com/r/b4000345-1ae5-36b5-a791-2792e83a28b6/bullish-and-bearish-reversals-market?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,Finding the stocks that have changed direction.
AKRX,AKRX:UW,BBG000BBJN38,Red-Hot Biotech Companies Highlight Jefferies Top Stocks to Buy,2017-03-06 15:20:23 +0000,http://finance.yahoo.com/news/red-hot-biotech-companies-highlight-152023423.html,Red-Hot Biotech Companies Highlight Jefferies Top Stocks to Buy
AKRX,AKRX:UW,BBG000BBJN38,New Strong Sell Stocks for March 6th,2017-03-06 15:10:03 +0000,http://finance.yahoo.com/news/strong-sell-stocks-march-6th-151003976.html,New Strong Sell Stocks for March 6th
AKRX,AKRX:UW,BBG000BBJN38,"Analysts' Actions -- FedEx, GoPro, Garmin, HP and More",2017-03-06 13:07:00 +0000,http://finance.yahoo.com/news/analysts-actions-fedex-gopro-garmin-130700564.html,"Analysts' Actions -- FedEx, GoPro, Garmin, HP and More"
AKRX,AKRX:UW,BBG000BBJN38,Perrigo Joins Firms With Generic Drugs Under U.S. Glare,2017-03-03 15:25:46 +0000,https://www.bloomberg.com/news/articles/2017-03-03/perrigo-joins-list-of-firms-with-generic-drugs-under-u-s-glare?cmpid=yhoo.headline,Perrigo Joins Firms With Generic Drugs Under U.S. Glare
AKRX,AKRX:UW,BBG000BBJN38,"Akorn, Inc. :AKRX-US: Earnings Analysis: Q4, 2016 By the Numbers : March 2, 2017",2017-03-02 15:05:08 +0000,http://www.capitalcube.com/blog/index.php/akorn-inc-akrx-us-earnings-analysis-q4-2016-by-the-numbers-march-2-2017/,"Akorn, Inc. :AKRX-US: Earnings Analysis: Q4, 2016 By the Numbers : March 2, 2017"
AKRX,AKRX:UW,BBG000BBJN38,"AKORN INC Files SEC form 8-K, Regulation FD Disclosure",2017-03-02 13:37:33 +0000,http://biz.yahoo.com/e/170302/akrx8-k.html,"AKORN INC Files SEC form 8-K, Regulation FD Disclosure"
AKRX,AKRX:UW,BBG000BBJN38,"Akorn Receives FDA Approval for Ephedrine Sulfate Injection, USP",2017-03-02 13:25:26 +0000,http://finance.yahoo.com/news/akorn-receives-fda-approval-ephedrine-132526549.html,"[GlobeNewswire] - LAKE FOREST, Ill., March 02, 2017-- Akorn, Inc., a leading specialty generics pharmaceutical company, today announced that it has received approval from the U.S. Food and Drug Administration for its New ..."
AKRX,AKRX:UW,BBG000BBJN38,"8:25 am Akorn receives FDA approval for its NDA for Ephedrine Sulfate Injection, USP 50 mg/mL in 1 mL single dose ampule",2017-03-02 13:25:00 +0000,http://finance.yahoo.com/news/inplay-briefing-com-055139997.html#akrx,"8:25 am Akorn receives FDA approval for its NDA for Ephedrine Sulfate Injection, USP 50 mg/mL in 1 mL single dose ampule"
AKRX,AKRX:UW,BBG000BBJN38,7 Stocks Trending With Monster Volume,2017-03-02 12:00:00 +0000,https://www.thestreet.com/story/14022901/1/7-stocks-trending-with-monster-volume.html?puc=yahoo&cm_ven=YAHOO,7 Stocks Trending With Monster Volume
AKRX,AKRX:UW,BBG000BBJN38,Akorn Inc Earnings Call scheduled for 10:00 am ET today,2017-03-01 15:00:00 +0000,http://biz.yahoo.com/cc/6/155516.html,Akorn Inc Earnings Call scheduled for 10:00 am ET today
AKRX,AKRX:UW,BBG000BBJN38,Akorn meets 4Q profit forecasts,2017-03-01 12:43:27 +0000,http://sg.finance.yahoo.com/news/akorn-meets-4q-profit-forecasts-124327570.html,Akorn meets 4Q profit forecasts
AKRX,AKRX:UW,BBG000BBJN38,"AKORN INC Files SEC form 8-K, Results of Operations and Financial Condition",2017-03-01 12:31:19 +0000,http://biz.yahoo.com/e/170301/akrx8-k.html,"AKORN INC Files SEC form 8-K, Results of Operations and Financial Condition"
AKRX,AKRX:UW,BBG000BBJN38,Q4 2016 Akorn Inc Earnings Release - Before Market Open,2017-03-01 12:07:03 +0000,http://biz.yahoo.com/research/earncal/20170301.html?t=akrx,Q4 2016 Akorn Inc Earnings Release - Before Market Open
AKRX,AKRX:UW,BBG000BBJN38,Akorn Provides Fourth Quarter and Full Year 2016 Results and Outlines Full Year 2017 Guidance,2017-03-01 12:00:00 +0000,http://finance.yahoo.com/news/akorn-provides-fourth-quarter-full-120000751.html,"[GlobeNewswire] - -Q4 2016 Revenue Increase to $284 Million-. -Q4 2016 GAAP Diluted EPS Decrease of 4% to $0.26; Q4 2016 Adjusted Diluted EPS Decrease of 3% to $0.58-. -FY 2016 Revenue Increase of 13% to $1,117 Million-...."
AKRX,AKRX:UW,BBG000BBJN38,Akorn Q4 16 Earnings Conference Call At 10:00 AM ET,2017-03-01 08:59:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/c9QBf_jp0t0/akorn-q4-16-earnings-conference-call-at-1000-am-et-20170301-00831,Akorn Q4 16 Earnings Conference Call At 10:00 AM ET
AKRX,AKRX:UW,BBG000BBJN38,Akorn Inc Earnings Decline 5% In Q4,2017-03-01 07:11:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/gV0URvyFOcc/akorn-inc-earnings-decline-5-in-q4-20170301-00469,Akorn Inc Earnings Decline 5% In Q4
AKRX,AKRX:UW,BBG000BBJN38,"AKRX, LXRX Get FDA Nod, KITE Flies Higher, SRPT Plunges On Dull Outlook",2017-03-01 02:33:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/U1g_1km_G0w/akrx-lxrx-get-fda-nod-kite-flies-higher-srpt-plunges-on-dull-outlook-20170301-00110,"AKRX, LXRX Get FDA Nod, KITE Flies Higher, SRPT Plunges On Dull Outlook"
AKRX,AKRX:UW,BBG000BBJN38,"Akorn Receives Approval for Mycophenolate Mofetil for Injection, USP",2017-02-28 22:30:00 +0000,http://finance.yahoo.com/news/akorn-receives-approval-mycophenolate-mofetil-223000785.html,"[GlobeNewswire] - LAKE FOREST, Ill., Feb. 28, 2017-- Akorn, Inc., a leading specialty pharmaceutical company, today announced that it has received approval from the U.S. Food and Drug Administration for its Abbreviated ..."
AKRX,AKRX:UW,BBG000BBJN38,Implied PPH Analyst Target Price: $63,2017-02-28 19:52:20 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/glN9yE0AIbE/implied-pph-analyst-target-price-63-cm754393,Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel we have compared the trading price of each holding against the average analyst 12 month forward target price and computed the weighted average implied analyst target price for the ETF itself For
AKRX,AKRX:UW,BBG000BBJN38,"First Light Asset Management, LLC Buys Immunomedics, NeoGenomics, Shire PLC, Sells BioScrip, ...",2017-02-17 22:51:26 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/qr38xXiAsug/first-light-asset-management-llc-buys-immunomedics-neogenomics-shire-plc-sells-bioscrip-cm749896,First Light Asset Management LLC New Purchases IBB MGNX XLV IHI IRMD ABBV Added Positions IMMU NEO SHPG TECH CELG VCYT OXFD HSTM BLUE AMED Reduced Positions PETX LMAT TLGT RTIX STRM SPNC AVGR HBIO NVS ENZ Sold Out BIOS
AKRX,AKRX:UW,BBG000BBJN38,"Akorn, Inc. breached its 50 day moving average in a Bearish Manner : AKRX-US : February 13, 2017",2017-02-13 12:46:49 +0000,http://www.capitalcube.com/blog/index.php/akorn-inc-breached-its-50-day-moving-average-in-a-bearish-manner-akrx-us-february-13-2017/,"Akorn, Inc. breached its 50 day moving average in a Bearish Manner : AKRX-US : February 13, 2017"
AKRX,AKRX:UW,BBG000BBJN38,Akorn to Report Fourth Quarter and Full Year 2016 Results,2017-02-06 12:30:00 +0000,http://finance.yahoo.com/news/akorn-report-fourth-quarter-full-123000959.html,"[GlobeNewswire] - LAKE FOREST, Ill., Feb. 06, 2017-- Akorn, Inc., a leading specialty generic pharmaceutical company, today announced that it plans to issue a press release on Wednesday, March 1, 2017 outlining the fourth ..."
AKRX,AKRX:UW,BBG000BBJN38,8 Stocks Trading Below Peter Lynch Value,2017-01-23 19:46:45 +0000,http://finance.yahoo.com/news/8-stocks-trading-below-peter-194645375.html,8 Stocks Trading Below Peter Lynch Value
AKRX,AKRX:UW,BBG000BBJN38,"Commit To Buy Akorn At $17.50, Earn 12.6% Using Options",2017-01-20 19:38:51 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0-TLX9uosgk/commit-to-buy-akorn-at-1750-earn-126-using-options-cm736162,Investors eyeing a purchase of Akorn Inc Symbol AKRX shares but cautious about paying the going market price of 20 59 share might benefit from considering selling puts among the alternative strategies at their disposal One interesting put contract in particular is the January 2018 put
AKRX,AKRX:UW,BBG000BBJN38,Value Investing 2017: 3 Stocks to Put on Your Radar,2017-01-19 18:27:25 +0000,http://www.fool.com/investing/2017/01/18/value-investing-2017-3-stocks-to-put-on-your-radar.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Value Investing 2017: 3 Stocks to Put on Your Radar
AKRX,AKRX:UW,BBG000BBJN38,Casualty List Has Done Well; Here's the Latest,2017-01-19 00:00:27 +0000,http://finance.yahoo.com/news/casualty-list-done-well-heres-000027538.html,Casualty List Has Done Well; Here's the Latest
AKRX,AKRX:UW,BBG000BBJN38,Value Investing 2017: 3 Stocks to Put on Your Radar,2017-01-18 22:38:06 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/g4quWbjKl90/value-investing-2017-3-stocks-to-put-on-your-radar-cm735078,Image source Getty Images It s easier said than done but one of the best ways to ensure above average returns is to buy great companies at great prices and hold on for a long time Maybe you ve honed a value investing strategy over the years or are looking to start in 2017
AKRX,AKRX:UW,BBG000BBJN38,"Akorn, Inc. breached its 50 day moving average in a Bearish Manner : AKRX-US : January 18, 2017",2017-01-18 13:04:34 +0000,http://www.capitalcube.com/blog/index.php/akorn-inc-breached-its-50-day-moving-average-in-a-bearish-manner-akrx-us-january-18-2017/,"Akorn, Inc. breached its 50 day moving average in a Bearish Manner : AKRX-US : January 18, 2017"
AKRX,AKRX:UW,BBG000BBJN38,Akorn To Present At J.P Morgan Conference; Webcast At 7:30 PM ET,2017-01-09 15:02:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/4D1zUfRKyWo/akorn-to-present-at-jp-morgan-conference-webcast-at-730-pm-et-20170109-00881,Akorn To Present At J.P Morgan Conference; Webcast At 7:30 PM ET
AKRX,AKRX:UW,BBG000BBJN38,These Indicators Show the Bull Market Has More Room to Run in —…–7,2017-01-04 14:37:08 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/WrJ9FZ8u1CM/these-indicators-show-the-bull-market-has-more-room-to-run-in-7-cm729160,Although the S amp P 500 is overvalued by P E current 25 76 average 15 63 and Shiller P E current 27 9 average 16 7 measures the market still has more upside according to the two economic indicators that I monitor the Chemical Activity Barometer CAB and the Chicago Fed
AKRX,AKRX:UW,BBG000BBJN38,"Akorn, Inc. – Value Analysis (NASDAQ:AKRX) : January 3, 2017",2017-01-03 15:17:50 +0000,http://www.capitalcube.com/blog/index.php/akorn-inc-value-analysis-nasdaqakrx-january-3-2017/,"Akorn, Inc. – Value Analysis (NASDAQ:AKRX) : January 3, 2017"
AKRX,AKRX:UW,BBG000BBJN38,"Akorn, Inc. breached its 50 day moving average in a Bullish Manner : AKRX-US : January 2, 2017",2017-01-02 12:07:39 +0000,http://www.capitalcube.com/blog/index.php/akorn-inc-breached-its-50-day-moving-average-in-a-bullish-manner-akrx-us-january-2-2017/,"Akorn, Inc. breached its 50 day moving average in a Bullish Manner : AKRX-US : January 2, 2017"
AKRX,AKRX:UW,BBG000BBJN38,Integer Investments: Akorn Has 100% Upside Potential,2017-01-02 02:26:59 +0000,http://finance.yahoo.com/news/integer-investments-akorn-100-upside-022659954.html,Integer Investments: Akorn Has 100% Upside Potential
AKRX,AKRX:UW,BBG000BBJN38,Akorn to Present at 35th Annual J.P Morgan Healthcare Conference,2016-12-21 12:30:00 +0000,http://finance.yahoo.com/news/akorn-present-35th-annual-j-123000137.html,"[GlobeNewswire] - LAKE FOREST, Ill., Dec. 21, 2016-- Akorn, Inc., a leading specialty generic pharmaceutical company, today announced that Akorn’ s CEO, Raj Rai, will present at the 35 th Annual J.P. Morgan Healthcare Conference ..."
AKRX,AKRX:UW,BBG000BBJN38,"AKORN INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders",2016-12-19 22:06:49 +0000,http://biz.yahoo.com/e/161219/akrx8-k.html,"AKORN INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders"
AKRX,AKRX:UW,BBG000BBJN38,[$$] Akorn Is a Best Idea for 2017,2016-12-15 12:54:00 +0000,http://www.barrons.com/articles/akorn-is-a-best-idea-for-2017-1481806493?mod=yahoobarrons&ru=yahoo,[$$] Akorn Is a Best Idea for 2017
AKRX,AKRX:UW,BBG000BBJN38,"Why Baytex Energy, Akorn, and Alamos Gold Jumped Today",2016-12-13 00:56:16 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/vr6fpQRp16o/why-baytex-energy-akorn-and-alamos-gold-jumped-today-cm720435,The stock market has been on a big record run lately but Monday began a new week on a mixed note The Dow Jones Industrials powered ahead to a fresh all time high but the S amp P 500 and Nasdaq Composite fell back from record levels Technology stocks held back the broader averages
AKRX,AKRX:UW,BBG000BBJN38,"Why Baytex Energy, Akorn, and Alamos Gold Jumped Today",2016-12-12 22:52:07 +0000,http://www.fool.com/investing/2016/12/12/why-baytex-energy-akorn-and-alamos-gold-jumped-tod.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,"Why Baytex Energy, Akorn, and Alamos Gold Jumped Today"
AKRX,AKRX:UW,BBG000BBJN38,"Why Akorn, Inc. Shares Are Surging 10%",2016-12-12 21:57:30 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/oj_dVXqb5tY/why-akorn-inc-shares-are-surging-10-cm720361,IMAGE SOURCE GETTY IMAGES What happened After the company announced that an important facility was recently reinspected by the U S Food and Drug Administration and that no Form 483 deficiencies were observed shares in Akorn NASDAQ AKRX rallied 10 earlier today So
AKRX,AKRX:UW,BBG000BBJN38,"Why Akorn, Inc. Shares Are Surging 10%",2016-12-12 20:04:36 +0000,http://www.fool.com/investing/general/2016/12/12/why-akorn-inc-shares-are-surging-10.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,"Why Akorn, Inc. Shares Are Surging 10%"
AKRX,AKRX:UW,BBG000BBJN38,"AKORN INC Files SEC form 8-K, Other Events",2016-12-12 12:55:05 +0000,http://biz.yahoo.com/e/161212/akrx8-k.html,"AKORN INC Files SEC form 8-K, Other Events"
AKRX,AKRX:UW,BBG000BBJN38,Akorn Announces Completion of FDA Re-inspection of Decatur Facility,2016-12-12 12:00:00 +0000,http://finance.yahoo.com/news/akorn-announces-completion-fda-inspection-120000876.html,"[GlobeNewswire] - LAKE FOREST, Ill., Dec. 12, 2016-- Akorn, Inc., a leading specialty pharmaceutical company, today announced that the U.S. Food and Drug Administration conducted a re-inspection of its Decatur, Illinois ..."
AKRX,AKRX:UW,BBG000BBJN38,Wall Street analysts expect these mid-cap stocks to rise up to 53% in 2017,2016-12-09 17:22:53 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=8FDCF0F8-BC91-11E6-A55C-7986D69D84E4&siteid=yhoof2,Wall Street analysts expect these mid-cap stocks to rise up to 53% in 2017
AKRX,AKRX:UW,BBG000BBJN38,Why Shares of Drug Maker Akorn Are a Buy After Losing 50% in 2016,2016-12-08 17:56:00 +0000,https://www.thestreet.com/story/13917566/1/why-shares-of-drug-maker-akorn-are-a-buy-after-losing-50-in-2016.html?puc=yahoo&cm_ven=YAHOO,Why Shares of Drug Maker Akorn Are a Buy After Losing 50% in 2016
AKRX,AKRX:UW,BBG000BBJN38,"ETFs with exposure to Akorn, Inc. : December 8, 2016",2016-12-08 17:10:42 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-akorn-inc-december-8-2016/,"ETFs with exposure to Akorn, Inc. : December 8, 2016"
AKRX,AKRX:UW,BBG000BBJN38,3 Reasons Akorn Inc. Could Fall,2016-12-08 16:59:45 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ZvepkqkNiHw/3-reasons-akorn-inc-could-fall-cm718690,Image source Getty Images Specialty generic drug manufacturer Akorn Inc NASDAQ AKRX can t seem to catch a break If the company meets 2016 guidance it will have grown revenue and EPS over 250 since 2013 It has over 83 Abbreviated New Drug Applications ANDAs pending
AKRX,AKRX:UW,BBG000BBJN38,3 Reasons Akorn Inc. Could Fall,2016-12-08 15:35:09 +0000,http://www.fool.com/investing/2016/12/08/3-reasons-akorn-inc-could-fall.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,3 Reasons Akorn Inc. Could Fall
AKRX,AKRX:UW,BBG000BBJN38,Drug Stocks Topple On Donald Trump's Pledge To Bring Down Drug Prices,2016-12-07 21:12:13 +0000,http://www.investors.com/research/ibd-industry-themes/biotechs-topple-on-donald-trumps-pledge-to-bring-down-drug-prices/,Drug Stocks Topple On Donald Trump's Pledge To Bring Down Drug Prices
AKRX,AKRX:UW,BBG000BBJN38,3 Reasons Akorn Inc. Stock Could Rise,2016-12-02 14:49:35 +0000,http://www.fool.com/investing/2016/12/02/3-reasons-akorn-inc-stock-could-rise.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,3 Reasons Akorn Inc. Stock Could Rise
AKRX,AKRX:UW,BBG000BBJN38,"Health Care Sector Update for 12/01/2016: AKRX,HTBX,ARDM",2016-12-01 20:52:44 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/UHahAXRN5wk/health-care-sector-update-for-12012016-akrxhtbxardm-cm716613,Top Health Care StocksTop Health Care Stocks JNJ 0 12 JNJ 0 12 PFE 1 80 PFE 1 80 MRK 1 13 MRK 1 13 ABT 0 54 ABT 0 54 AMGN 0 93 AMGN 0 93 Health care stocks were mostly lower today with the NYSE Health Care Index slipping about 0 6 while shares of health care companies in
AKRX,AKRX:UW,BBG000BBJN38,Coverage initiated on Akorn by Goldman,2016-12-01 12:13:48 +0000,http://finance.yahoo.com/q/ud?s=AKRX,Coverage initiated on Akorn by Goldman
AKRX,AKRX:UW,BBG000BBJN38,Akorn Launches Ibuprofen Oral Suspension,2016-11-29 12:30:00 +0000,http://finance.yahoo.com/news/akorn-launches-ibuprofen-oral-suspension-123000223.html,"[GlobeNewswire] - LAKE FOREST, Ill., Nov. 29, 2016-- Akorn, Inc., a leading specialty pharmaceutical company, today announced that it has launched the prescription version of Ibuprofen 100 mg/5mL oral suspension in 118 ..."
AKRX,AKRX:UW,BBG000BBJN38,Akorn To Present At Piper Jaffray Healthcare Conference; Webcast At 8:30 AM ET,2016-11-29 07:30:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/mhUu849QUlo/akorn-to-present-at-piper-jaffray-healthcare-conference-webcast-at-830-am-et-20161129-00247,Akorn To Present At Piper Jaffray Healthcare Conference; Webcast At 8:30 AM ET
AKRX,AKRX:UW,BBG000BBJN38,"AKORN INC Files SEC form 8-K, Other Events",2016-11-28 22:30:22 +0000,http://biz.yahoo.com/e/161128/akrx8-k.html,"AKORN INC Files SEC form 8-K, Other Events"
AKRX,AKRX:UW,BBG000BBJN38,Akorn Invalidates Durezol® Patent Via Inter Partes Review Proceeding,2016-11-28 22:15:00 +0000,http://finance.yahoo.com/news/akorn-invalidates-durezol-patent-via-221500971.html,"[GlobeNewswire] - LAKE FOREST, Ill., Nov. 28, 2016-- Akorn, Inc., a leading specialty pharmaceutical company, today announced that on November 22, 2016, the Patent Trial and Appeal Board ruled in favor of Akorn in its inter ..."
AKRX,AKRX:UW,BBG000BBJN38,"How Akorn, Inc. (AKRX) Stacks Up Against Its Peers",2016-11-26 22:49:00 +0000,http://www.insidermonkey.com/blog/how-akorn-inc-akrx-stacks-up-against-its-peers-492524/,"How Akorn, Inc. (AKRX) Stacks Up Against Its Peers"
AKRX,AKRX:UW,BBG000BBJN38,Is Mallinckrodt (MNK) Poised for a Beat in Q4 Earnings?,2016-11-23 16:07:02 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/MYx9k-cODgI/is-mallinckrodt-mnk-poised-for-a-beat-in-q4-earnings-cm713271,Mallinckrodt plc MNK is set to report fourth quarter fiscal 2016 results on Nov 29 The company s track has been impressive so far It has beaten estimates in each of the last four quarters with a positive average earnings surprise of 11 9 Let s see how things are shaping up for
AKRX,AKRX:UW,BBG000BBJN38,"Drug Makers Sued for Price Collusion (NVS, TEVA)",2016-11-20 17:30:00 +0000,http://www.investopedia.com/news/unions-drug-makers-colluded-prices-nvs-teva/?partner=YahooSA,"Drug Makers Sued for Price Collusion (NVS, TEVA)"
AKRX,AKRX:UW,BBG000BBJN38,Akorn to Present at Piper Jaffray 28th Annual Healthcare Conference,2016-11-16 13:30:00 +0000,http://finance.yahoo.com/news/akorn-present-piper-jaffray-28th-133000768.html,"[GlobeNewswire] - LAKE FOREST, Ill., Nov. 16, 2016-- Akorn, Inc., a leading specialty generic pharmaceutical company, today announced that Akorn’ s Chief Financial Officer, Duane Portwood, will present at the Piper Jaffray ..."
AKRX,AKRX:UW,BBG000BBJN38,Trouble Developing for Generic Pharma Stocks?,2016-11-11 19:50:39 +0000,http://finance.yahoo.com/tumblr/blog-trouble-developing-for-generic-pharma-stocks-195047922.html,Trouble Developing for Generic Pharma Stocks?
AKRX,AKRX:UW,BBG000BBJN38,"ETF’s with exposure to Akorn, Inc. : November 10, 2016",2016-11-10 16:58:44 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-akorn-inc-november-10-2016/,"ETF’s with exposure to Akorn, Inc. : November 10, 2016"
AKRX,AKRX:UW,BBG000BBJN38,"Akorn, Inc. :AKRX-US: Earnings Analysis: Q3, 2016 By the Numbers : November 9, 2016",2016-11-09 15:42:59 +0000,http://www.capitalcube.com/blog/index.php/akorn-inc-akrx-us-earnings-analysis-q3-2016-by-the-numbers-november-9-2016/,"Akorn, Inc. :AKRX-US: Earnings Analysis: Q3, 2016 By the Numbers : November 9, 2016"
AKRX,AKRX:UW,BBG000BBJN38,Akorn 3Q Adjusted EPS Beats Street (AKRX),2016-11-04 18:35:00 +0000,http://www.investopedia.com/news/akorn-3q-net-38-cents-share-vs-39-cents-akrx/?partner=YahooSA,Akorn 3Q Adjusted EPS Beats Street (AKRX)
AKRX,AKRX:UW,BBG000BBJN38,"Despite Department Of Justice Investigation, Now May Be The Time To Buy Generic Drug Stocks",2016-11-04 17:53:22 +0000,http://finance.yahoo.com/news/despite-department-justice-investigation-now-175322739.html,"Despite Department Of Justice Investigation, Now May Be The Time To Buy Generic Drug Stocks"
AKRX,AKRX:UW,BBG000BBJN38,"The Ridiculous Reason Akorn, Inc. Shares Dropped as Much as 17.4% Today",2016-11-03 23:08:06 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/qxoTjYp8xdM/the-ridiculous-reason-akorn-inc-shares-dropped-as-much-as-174-today-cm703716,Image source Getty Images What happened Specialty generic pharmaceutical manufacturer Akorn NASDAQ AKRX reported third quarter 2016 earnings this morning which promptly sent shares lower Investors may be scratching their heads as to why though So what Ironically
AKRX,AKRX:UW,BBG000BBJN38,"The Ridiculous Reason Akorn, Inc. Shares Dropped as Much as 17.4% Today",2016-11-03 21:24:01 +0000,http://www.fool.com/investing/2016/11/03/the-ridiculous-reason-akorn-inc-shares-dropped-as.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,"The Ridiculous Reason Akorn, Inc. Shares Dropped as Much as 17.4% Today"
AKRX,AKRX:UW,BBG000BBJN38,Health Sector Down As Report of Industry Price Collusion Surfaces,2016-11-03 21:03:00 +0000,https://www.thestreet.com/story/13880341/1/health-sector-down-as-report-of-industry-price-collusion-surfaces.html?puc=yahoo&cm_ven=YAHOO,Health Sector Down As Report of Industry Price Collusion Surfaces
AKRX,AKRX:UW,BBG000BBJN38,Generic-Drug Makers Crash On Report DOJ Plans Collusion Charges,2016-11-03 20:59:43 +0000,http://www.investors.com/news/technology/generic-drugmakers-crash-on-report-doj-plans-collusion-charges/,Generic-Drug Makers Crash On Report DOJ Plans Collusion Charges
AKRX,AKRX:UW,BBG000BBJN38,Edited Transcript of AKRX earnings conference call or presentation 3-Nov-16 2:00pm GMT,2016-11-03 20:28:13 +0000,http://finance.yahoo.com/news/edited-transcript-akrx-earnings-conference-202813984.html,Edited Transcript of AKRX earnings conference call or presentation 3-Nov-16 2:00pm GMT
AKRX,AKRX:UW,BBG000BBJN38,"Top 5 medical distributors with good fundamentals : November 3, 2016",2016-11-03 16:44:36 +0000,http://www.capitalcube.com/blog/index.php/top-5-medical-distributors-with-good-fundamentals-november-3-2016/,"Top 5 medical distributors with good fundamentals : November 3, 2016"
AKRX,AKRX:UW,BBG000BBJN38,Akorn Inc Earnings Call scheduled for 10:00 am ET today,2016-11-03 14:00:00 +0000,http://biz.yahoo.com/cc/6/154186.html,Akorn Inc Earnings Call scheduled for 10:00 am ET today
AKRX,AKRX:UW,BBG000BBJN38,Akorn tops Street 3Q forecasts,2016-11-03 13:51:27 +0000,http://sg.finance.yahoo.com/news/akorn-tops-street-3q-forecasts-135127548.html,Akorn tops Street 3Q forecasts
AKRX,AKRX:UW,BBG000BBJN38,Akorn Provides Third Quarter 2016 Results,2016-11-03 11:18:11 +0000,http://www.publicnow.com/view/515A46DD8FF22B06074960B69F313B34E65AC70C,"[at noodls] - - Q3 2016 Revenue Increase of 11% to $284 million - - Q3 2016 GAAP EPS of$0.38; Adjusted Q3 2016 EPS of $0.56 - - Updates 2016 Revenue, EPS and Adjusted EBITDA Guidance - - Repurchased $25 Million of Shares ..."
AKRX,AKRX:UW,BBG000BBJN38,"AKORN INC Files SEC form 8-K, Results of Operations and Financial Condition",2016-11-03 11:16:13 +0000,http://biz.yahoo.com/e/161103/akrx8-k.html,"AKORN INC Files SEC form 8-K, Results of Operations and Financial Condition"
AKRX,AKRX:UW,BBG000BBJN38,Q3 2016 Akorn Inc Earnings Release - Before Market Open,2016-11-03 11:07:09 +0000,http://biz.yahoo.com/research/earncal/20161103.html?t=akrx,Q3 2016 Akorn Inc Earnings Release - Before Market Open
AKRX,AKRX:UW,BBG000BBJN38,Akorn Q3 16 Earnings Conference Call At 10:00 AM ET,2016-11-03 09:01:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/YfpUEaFsjt4/akorn-q3-16-earnings-conference-call-at-1000-am-et-20161103-00346,Akorn Q3 16 Earnings Conference Call At 10:00 AM ET
AKRX,AKRX:UW,BBG000BBJN38,"Akorn Q3 Profit Edges Down, Lifts FY16 Earnings Outlook",2016-11-03 07:24:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/eQisRxGLc0g/akorn-q3-profit-edges-down-lifts-fy16-earnings-outlook-20161103-01662,"Akorn Q3 Profit Edges Down, Lifts FY16 Earnings Outlook"
AKRX,AKRX:UW,BBG000BBJN38,"Drug Stocks Q3 Earnings Roster for Nov 3; ICPT, EXEL, AKRX",2016-11-02 13:17:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-bcqNT1wDlU/drug-stocks-q3-earnings-roster-for-nov-3-icpt-exel-akrx-cm702314,The Q3 earnings season moves into the last leg of its reporting cycle with 332 S amp P 500 members as of Nov 1 accounting for 74 1 of the index s total market capitalization having already reported results according to the Earnings Outlook report While total earnings for these
AKRX,AKRX:UW,BBG000BBJN38,"Drug Stocks Q3 Earnings Roster for Nov 3; ICPT, EXEL, AKRX",2016-11-02 12:03:12 +0000,http://finance.yahoo.com/news/drug-stocks-q3-earnings-roster-120312449.html,"Drug Stocks Q3 Earnings Roster for Nov 3; ICPT, EXEL, AKRX"
AKRX,AKRX:UW,BBG000BBJN38,"Robbins Arroyo LLP: Akorn, Inc. (AKRX) Misled Shareholders According to a Recently Filed Class Action",2016-10-28 17:52:00 +0000,http://finance.yahoo.com/news/robbins-arroyo-llp-akorn-inc-175200744.html,"[Business Wire] - Shareholder rights law firm Robbins Arroyo LLP announces that a class action complaint was filed against Akorn, Inc. in the U.S. District Court for the Southern District of New York."
AKRX,AKRX:UW,BBG000BBJN38,"Valeant Pharmaceuticals: Stay Far Away, JPMorgan Says",2016-10-24 17:09:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/10/24/valeant-pharmaceuticals-stay-far-away-jpmorgan-says/?mod=yahoobarrons&ru=yahoo,"Valeant Pharmaceuticals: Stay Far Away, JPMorgan Says"
AKRX,AKRX:UW,BBG000BBJN38,Akorn Plant Cited For 6 FDA Violations (AKRX),2016-10-21 15:05:00 +0000,http://www.investopedia.com/news/akorns-illinois-plant-gets-fda-warning-akrx/?partner=YahooSA,Akorn Plant Cited For 6 FDA Violations (AKRX)
AKRX,AKRX:UW,BBG000BBJN38,"Commit To Buy Akorn At $20, Earn 10.2% Using Options",2016-10-20 17:25:33 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/wSoXVyFiHsI/commit-to-buy-akorn-at-20-earn-102-using-options-cm696056,Investors eyeing a purchase of Akorn Inc Symbol AKRX shares but cautious about paying the going market price of 27 43 share might benefit from considering selling puts among the alternative strategies at their disposal One interesting put contract in particular is the January 2018 put
AKRX,AKRX:UW,BBG000BBJN38,Akorn Announces Third Quarter 2016 Earnings Release and Conference Call Information,2016-10-13 12:40:02 +0000,http://www.publicnow.com/view/B15C94BB1068F7AD998CEEA75120185CAB47658E,"[at noodls] - LAKE FOREST, Ill., Oct. 13, 2016 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq:AKRX), a leading specialty generic pharmaceutical company, today announced that it plans to issue a press release on Thursday, November ..."
AKRX,AKRX:UW,BBG000BBJN38,Bullish Two Hundred Day Moving Average Cross - AKRX,2016-10-10 22:17:30 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/mfcKjZ4nd9I/bullish-two-hundred-day-moving-average-cross-akrx-cm691341,In trading on Monday shares of Akorn Inc Symbol AKRX crossed above their 200 day moving average of 28 17 changing hands as high as 28 42 per share Akorn Inc shares are currently trading up about 3 8 on the day The chart below shows the one year performance of AKRX shares versus its
AKRX,AKRX:UW,BBG000BBJN38,Peek Under The Hood: XPH Has 25% Upside,2016-09-23 14:21:42 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Txe4vJIQY8Q/peek-under-the-hood-xph-has-25-upside-cm683722,Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel we have compared the trading price of each holding against the average analyst 12 month forward target price and computed the weighted average implied analyst target price for the ETF itself For the
AKRX,AKRX:UW,BBG000BBJN38,"Akorn (AKRX) Stock Gains, Rating Raised at Piper Jaffray",2016-09-15 13:33:00 +0000,https://www.thestreet.com/story/13741319/1/akorn-akrx-stock-gains-rating-raised-at-piper-jaffray.html?puc=yahoo&cm_ven=YAHOO,"Akorn (AKRX) Stock Gains, Rating Raised at Piper Jaffray"
AKRX,AKRX:UW,BBG000BBJN38,Hologic To Present At Morgan Stanley Conference; Webcast At 12:20 PM ET,2016-09-13 11:20:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/8aiekqq0MtQ/hologic-to-present-at-morgan-stanley-conference-webcast-at-1220-pm-et-20160913-00786,Hologic To Present At Morgan Stanley Conference; Webcast At 12:20 PM ET
AKRX,AKRX:UW,BBG000BBJN38,Akorn To Present At Morgan Stanley Conference; Webcast At 12:20 PM ET,2016-09-13 11:20:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/MP_qlDp1bS4/akorn-to-present-at-morgan-stanley-conference-webcast-at-1220-pm-et-20160913-00785,Akorn To Present At Morgan Stanley Conference; Webcast At 12:20 PM ET
AKRX,AKRX:UW,BBG000BBJN38,What’s Expected from the Branded Consumer Healthcare Segment?,2016-09-09 20:04:05 +0000,http://marketrealist.com/2016/09/unfavorable-product-mix-expected-lower-branded-consumer-healthcare-segments-performance-2016/?utm_source=yahoo&utm_medium=feed,What’s Expected from the Branded Consumer Healthcare Segment?
AKRX,AKRX:UW,BBG000BBJN38,5 Stocks to Trade for Big Breakout Gains,2016-09-09 14:59:00 +0000,https://www.thestreet.com/story/13699728/1/5-stocks-to-trade-for-big-breakout-gains.html?puc=yahoo&cm_ven=YAHOO,5 Stocks to Trade for Big Breakout Gains
AKRX,AKRX:UW,BBG000BBJN38,"ETF’s with exposure to Akorn, Inc. : September 1, 2016",2016-09-01 13:25:38 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-akorn-inc-september-1-2016/,"ETF’s with exposure to Akorn, Inc. : September 1, 2016"
AKRX,AKRX:UW,BBG000BBJN38,Akorn in 2016: What Are Its Key Risk Factors?,2016-08-30 14:04:39 +0000,http://marketrealist.com/2016/08/key-risks-faced-akorn-2016/?utm_source=yahoo&utm_medium=feed,Akorn in 2016: What Are Its Key Risk Factors?
AKRX,AKRX:UW,BBG000BBJN38,Akorn Expected to Report Strong Revenue Growth in 2016,2016-08-30 12:04:41 +0000,http://marketrealist.com/2016/08/akorn-expected-report-strong-revenue-growth-2016/?utm_source=yahoo&utm_medium=feed,Akorn Expected to Report Strong Revenue Growth in 2016
AKRX,AKRX:UW,BBG000BBJN38,Your Complete Guide to the Generic Drug Industry,2016-08-29 21:13:09 +0000,http://finance.yahoo.com/news/complete-guide-generic-drug-industry-211309714.html,Your Complete Guide to the Generic Drug Industry
AKRX,AKRX:UW,BBG000BBJN38,Akorn’s Robust Research and Development Pipeline: A Growth Driver,2016-08-29 20:04:11 +0000,http://marketrealist.com/2016/08/akorns-robust-research-development-pipeline-expected-drive-companys-growth-2016/?utm_source=yahoo&utm_medium=feed,Akorn’s Robust Research and Development Pipeline: A Growth Driver
AKRX,AKRX:UW,BBG000BBJN38,Analyst Recommendations for Akorn in 2016,2016-08-29 19:04:10 +0000,http://marketrealist.com/2016/08/analyst-recommendations-akorn-inc-2016/?utm_source=yahoo&utm_medium=feed,Analyst Recommendations for Akorn in 2016
AKRX,AKRX:UW,BBG000BBJN38,Akorn’s 2016 Valuation Multiples Compared to Peers,2016-08-29 16:34:41 +0000,http://marketrealist.com/2016/08/akorns-2016-valuation-multiples-compared-peers/?utm_source=yahoo&utm_medium=feed,Akorn’s 2016 Valuation Multiples Compared to Peers
AKRX,AKRX:UW,BBG000BBJN38,Akorn Relaunches Ofloxacin Otic Solution,2016-08-25 12:38:02 +0000,http://www.publicnow.com/view/D8C7399A5386BCAEF9F28FB204BE914D26EF1E99,"[at noodls] - LAKE FOREST, Ill., Aug. 25, 2016 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq:AKRX), a leading specialty pharmaceutical company, today announced that it has relaunched Ofloxacin Otic Solution 0.3%, a sterile ..."
AKRX,AKRX:UW,BBG000BBJN38,"AKORN INC Files SEC form 8-K, Regulation FD Disclosure",2016-08-25 12:36:21 +0000,http://biz.yahoo.com/e/160825/akrx8-k.html,"AKORN INC Files SEC form 8-K, Regulation FD Disclosure"
AKRX,AKRX:UW,BBG000BBJN38,Akorn Relaunches Ofloxacin Otic Solution,2016-08-25 08:38:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/P0wswE52TEo/akorn-relaunches-ofloxacin-otic-solution-20160825-00380,Akorn Relaunches Ofloxacin Otic Solution
AKRX,AKRX:UW,BBG000BBJN38,Akorn Breaks Below 200-Day Moving Average - Notable for AKRX,2016-08-24 23:41:22 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Wla-Yza8e54/akorn-breaks-below-200-day-moving-average-notable-for-akrx-cm669831,"In trading on Wednesday, shares of Akorn Inc (Symbol AKRX) crossed below their 200 day moving average of $29.07, changing hands as low as $27.73 per share. Akorn Inc shares are currently trading down about 5.2% on the day."
AKRX,AKRX:UW,BBG000BBJN38,Akorn to Present at Morgan Stanley Global Healthcare Conference,2016-08-24 12:30:00 +0000,http://finance.yahoo.com/news/akorn-present-morgan-stanley-global-123000557.html,"[GlobeNewswire] - LAKE FOREST, Ill., Aug. 24, 2016-- Akorn, Inc., a leading specialty generic pharmaceutical company, today announced that Akorn’ s CEO, Raj Rai, will participate in a fireside chat at the Morgan Stanley ..."
AKRX,AKRX:UW,BBG000BBJN38,'Mad Money' Lightning Round: Take Nucor Over U.S. Steel,2016-08-24 10:00:00 +0000,https://www.thestreet.com/story/13630789/1/mad-money-lightning-round-take-nucor-over-u-s-steel.html?puc=yahoo&cm_ven=YAHOO,'Mad Money' Lightning Round: Take Nucor Over U.S. Steel
AKRX,AKRX:UW,BBG000BBJN38,PPH's Holdings Imply 16% Gain Potential,2016-08-22 13:42:47 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/hQX31cVqYY4/pphs-holdings-imply-16-gain-potential-cm668287,"Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel , we have compared the trading price of each holding against the average analyst 12 month forward target price, and computed the weighted average"
AKRX,AKRX:UW,BBG000BBJN38,What Are Analysts Recommending for Teva Pharmaceutical in 2016?,2016-08-19 15:25:35 +0000,http://marketrealist.com/2016/08/analyst-recommendations-teva-pharmaceutical-2016/?utm_source=yahoo&utm_medium=feed,What Are Analysts Recommending for Teva Pharmaceutical in 2016?
AKRX,AKRX:UW,BBG000BBJN38,Mylan Is Expected to Witness Robust Revenue Growth in 2016,2016-08-18 13:05:54 +0000,http://marketrealist.com/2016/08/mylan-expected-witness-robust-revenue-growth-2016/?utm_source=yahoo&utm_medium=feed,Mylan Is Expected to Witness Robust Revenue Growth in 2016
AKRX,AKRX:UW,BBG000BBJN38,Akorn Appoints Robert Monahan as Senior Vice President of Corporate Development,2016-08-18 13:01:01 +0000,http://www.publicnow.com/view/A388D93AE9D6242A819D21CBD023EF034030E85B,"[at noodls] - LAKE FOREST, Ill., Aug. 18, 2016 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq:AKRX), a leading specialty generic pharmaceutical company, today announced that Rob Monahan has recently joined Akorn as Senior ..."
AKRX,AKRX:UW,BBG000BBJN38,"AKORN INC Files SEC form 8-K, Regulation FD Disclosure",2016-08-18 12:36:11 +0000,http://biz.yahoo.com/e/160818/akrx8-k.html,"AKORN INC Files SEC form 8-K, Regulation FD Disclosure"
AKRX,AKRX:UW,BBG000BBJN38,What Are Analysts’ Recommendations for Mylan and Its Peers?,2016-08-17 19:10:13 +0000,http://marketrealist.com/2016/08/analysts-recommendations-mylan-peers-2016/?utm_source=yahoo&utm_medium=feed,What Are Analysts’ Recommendations for Mylan and Its Peers?
AKRX,AKRX:UW,BBG000BBJN38,"Akorn, Inc. breached its 50 day moving average in a Bearish Manner : AKRX-US : August 11, 2016",2016-08-11 12:09:14 +0000,http://www.capitalcube.com/blog/index.php/akorn-inc-breached-its-50-day-moving-average-in-a-bearish-manner-akrx-us-august-11-2016/,"Akorn, Inc. breached its 50 day moving average in a Bearish Manner : AKRX-US : August 11, 2016"
AKRX,AKRX:UW,BBG000BBJN38,"ETF’s with exposure to Akorn, Inc. : August 9, 2016",2016-08-09 17:16:12 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-akorn-inc-august-9-2016/,"ETF’s with exposure to Akorn, Inc. : August 9, 2016"
AKRX,AKRX:UW,BBG000BBJN38,"Akorn, Inc. :AKRX-US: Earnings Analysis: Q2, 2016 By the Numbers : August 8, 2016",2016-08-08 16:14:51 +0000,http://www.capitalcube.com/blog/index.php/akorn-inc-akrx-us-earnings-analysis-q2-2016-by-the-numbers-august-8-2016/,"Akorn, Inc. :AKRX-US: Earnings Analysis: Q2, 2016 By the Numbers : August 8, 2016"
AKRX,AKRX:UW,BBG000BBJN38,"Noteworthy ETF Outflows: XPH, MNK, AKRX, HZNP",2016-08-08 16:12:20 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/F2mUlrbye_Q/noteworthy-etf-outflows-xph-mnk-akrx-hznp-cm661845,"Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel , one standout is the SPDR S&P Pharmaceuticals ETF (Symbol XPH) where we have detected an approximate $32.8 million dollar outflow"
AKRX,AKRX:UW,BBG000BBJN38,Akorn (AKRX) Stock Drops Despite Q2 Beat,2016-08-04 19:18:00 +0000,https://www.thestreet.com/story/13665573/1/akorn-akrx-stock-drops-despite-q2-beat.html?puc=yahoo&cm_ven=YAHOO,Akorn (AKRX) Stock Drops Despite Q2 Beat
AKRX,AKRX:UW,BBG000BBJN38,Edited Transcript of AKRX earnings conference call or presentation 4-Aug-16 2:00pm GMT,2016-08-04 16:40:15 +0000,http://finance.yahoo.com/news/edited-transcript-akrx-earnings-conference-164015828.html,Edited Transcript of AKRX earnings conference call or presentation 4-Aug-16 2:00pm GMT
AKRX,AKRX:UW,BBG000BBJN38,Akorn Inc Earnings Call scheduled for 10:00 am ET today,2016-08-04 14:00:00 +0000,http://biz.yahoo.com/cc/8/153018.html,Akorn Inc Earnings Call scheduled for 10:00 am ET today
AKRX,AKRX:UW,BBG000BBJN38,Akorn tops Street 2Q forecasts,2016-08-04 13:33:36 +0000,http://sg.finance.yahoo.com/news/akorn-tops-street-2q-forecasts-133336034.html,Akorn tops Street 2Q forecasts
AKRX,AKRX:UW,BBG000BBJN38,"Akorn sets new stock buyback program, beats profit and sales expectations",2016-08-04 11:31:37 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=B59382C4-779D-4E81-9D5E-1E4D6DFB49B5&siteid=yhoof2,"Akorn sets new stock buyback program, beats profit and sales expectations"
AKRX,AKRX:UW,BBG000BBJN38,Akorn Provides Second Quarter 2016 Results,2016-08-04 11:22:07 +0000,http://www.publicnow.com/view/ECCFC9ABD446878EF126FD23441D014964BEC201,[at noodls] - - Q2 2016 Revenue Increase of 27% to $281 Million - - Q2 2016 GAAP EPS Increase of 85%to$0.50; Adjusted Q2 2016 EPS Increase of 41% to $0.58 - - Updates 2016 Revenue and EPS Guidance - - Board of Directors ...
AKRX,AKRX:UW,BBG000BBJN38,Q2 2016 Akorn Inc Earnings Release - Before Market Open,2016-08-04 11:07:07 +0000,http://biz.yahoo.com/research/earncal/20160804.html?t=akrx,Q2 2016 Akorn Inc Earnings Release - Before Market Open
AKRX,AKRX:UW,BBG000BBJN38,"AKORN INC Files SEC form 8-K, Results of Operations and Financial Condition, Other Events",2016-08-04 11:06:11 +0000,http://biz.yahoo.com/e/160804/akrx8-k.html,"AKORN INC Files SEC form 8-K, Results of Operations and Financial Condition, Other Events"
AKRX,AKRX:UW,BBG000BBJN38,Akorn Q2 16 Earnings Conference Call At 10:00 AM ET,2016-08-04 09:01:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Cvf2kQOWyYM/akorn-q2-16-earnings-conference-call-at-1000-am-et-20160804-00782,Akorn Q2 16 Earnings Conference Call At 10:00 AM ET
AKRX,AKRX:UW,BBG000BBJN38,Akorn Inc Q2 Earnings Rise 41%,2016-08-04 07:12:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/aQHn-aOE_Ak/akorn-inc-q2-earnings-rise-41-20160804-00371,Akorn Inc Q2 Earnings Rise 41%
AKRX,AKRX:UW,BBG000BBJN38,"Commit To Buy Akorn At $17.50, Earn 10.6% Using Options",2016-07-22 17:07:31 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/F-Xqc8uM5Hs/commit-to-buy-akorn-at-1750-earn-106-using-options-cm653410,"Investors eyeing a purchase of Akorn Inc (Symbol AKRX) shares, but tentative about paying the going market price of $32.17 share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in"
AKRX,AKRX:UW,BBG000BBJN38,Akorn Announces Second Quarter 2016 Earnings Release and Conference Call Information,2016-07-21 12:05:00 +0000,http://finance.yahoo.com/news/akorn-announces-second-quarter-2016-120500862.html,"[GlobeNewswire] - LAKE FOREST, Ill., July 21, 2016-- Akorn, Inc., a leading specialty generic pharmaceutical company, today announced that it plans to issue a press release on Thursday, August 4, 2016 outlining the second ..."
AKRX,AKRX:UW,BBG000BBJN38,10 Biotech And Specialty Pharma Bargains - Do You Have The Guts To Speculate?,2016-07-14 15:35:32 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/8PmCl4SBp0k/10-biotech-and-specialty-pharma-bargains-do-you-have-the-guts-to-speculate-cm644001,"By Chuck Carnevale Introduction There are many investors that believe that the stock market is currently overvalued. To a great extent, they may be correct as there is a lot of excessive valuation to be found in various segments"
AKRX,AKRX:UW,BBG000BBJN38,Pricing Stress may Weigh on Generic Drugmakers Ahead of Q2 Earnings,2016-07-12 20:27:00 +0000,https://www.thestreet.com/story/13636994/1/pricing-stress-may-weigh-on-generic-drugmakers-ahead-of-q2-earnings.html?puc=yahoo&cm_ven=YAHOO,Pricing Stress may Weigh on Generic Drugmakers Ahead of Q2 Earnings
AKRX,AKRX:UW,BBG000BBJN38,Coverage Initiated on Select Generic Drugs Makers Equities,2016-07-12 13:28:00 +0000,http://news.investornetwork.com/2016/07/12/coverage-initiated-on-select-generic-drugs-makers-equities/?1=1&1468330080,Coverage Initiated on Select Generic Drugs Makers Equities
AKRX,AKRX:UW,BBG000BBJN38,Understanding Akorn’s Focus on Inorganic Growth,2016-07-06 21:06:32 +0000,http://marketrealist.com/2016/06/akorn-inc-focuses-inorganic-growth-strengthen-business/?utm_source=yahoo&utm_medium=feed,Understanding Akorn’s Focus on Inorganic Growth
AKRX,AKRX:UW,BBG000BBJN38,"AKORN INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders, Other Events",2016-07-06 20:31:28 +0000,http://biz.yahoo.com/e/160706/akrx8-k.html,"AKORN INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders, Other Events"
AKRX,AKRX:UW,BBG000BBJN38,Alternate Dosage Forms Are Expected to Drive Akorn’s Growth in 2016,2016-07-01 14:43:55 +0000,http://marketrealist.com/2016/07/alternate-dosage-forms-expected-drive-akorn-incs-growth-2016/?utm_source=yahoo&utm_medium=feed,Alternate Dosage Forms Are Expected to Drive Akorn’s Growth in 2016
AKRX,AKRX:UW,BBG000BBJN38,Inside the Analyst Recommendations for Akorn in 2016,2016-06-30 20:24:31 +0000,http://marketrealist.com/2016/06/inside-analyst-recommendations-akorn-inc-2016/?utm_source=yahoo&utm_medium=feed,Inside the Analyst Recommendations for Akorn in 2016
AKRX,AKRX:UW,BBG000BBJN38,How Akorn’s Valuation Multiples Compare to Peers in 2016,2016-06-30 20:24:28 +0000,http://marketrealist.com/2016/06/akorn-inc-valuation-multiples-compare-peers-2016/?utm_source=yahoo&utm_medium=feed,How Akorn’s Valuation Multiples Compare to Peers in 2016
AKRX,AKRX:UW,BBG000BBJN38,"Notable ETF Outflow Detected - XPH, RLYP, AKRX, JAZZ",2016-06-14 16:07:24 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/BsuJWCjvPmU/notable-etf-outflow-detected-xph-rlyp-akrx-jazz-cm635159,"Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel , one standout is the SPDR S&P Pharmaceuticals ETF (Symbol XPH) where we have detected an approximate $79.8 million dollar outflow"
AKRX,AKRX:UW,BBG000BBJN38,Akorn (AKRX) Shares Cross Below 200 DMA,2016-06-13 22:02:15 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/sR_RLJ7BKTU/akorn-akrx-shares-cross-below-200-dma-cm634797,"In trading on Monday, shares of Akorn Inc (Symbol AKRX) crossed below their 200 day moving average of $29.60, changing hands as low as $29.54 per share. Akorn Inc shares are currently trading down about 1.9% on the day."
AKRX,AKRX:UW,BBG000BBJN38,"Akorn Updates Form S-8 Status by Filing Form 10-Q’s for First, Second and Third Quarters of 2015",2016-06-02 10:45:01 +0000,http://www.publicnow.com/view/6C6B573B33618D296B485A481D75D6A77554DB53,"[at noodls] - LAKE FOREST, Ill., June 02, 2016 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq:AKRX), a leading specialty generic pharmaceutical company, today announced that it has filed quarterly reports on Forms 10-Q with ..."
AKRX,AKRX:UW,BBG000BBJN38,Akorn to Present at Two Upcoming Investor Conferences,2016-05-31 12:42:05 +0000,http://www.publicnow.com/view/22E93FC2A64270BA7D474B19076EAE7FD4513770,"[at noodls] - LAKE FOREST, Ill., May 31, 2016 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq:AKRX), a leading specialty generic pharmaceutical company, today announced that management will be presenting at the Jefferies 2016 ..."
AKRX,AKRX:UW,BBG000BBJN38,"Akorn (AKRX) Shares March Higher, Can It Continue?",2016-05-19 15:04:57 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/yaEdafz1eYI/akorn-akrx-shares-march-higher-can-it-continue-cm623475,"As of late, it has definitely been a great time to be an investor in Akorn, Inc. AKRX . The stock has moved higher by 9.5% in the past month, while it is also above its 20 Day SMA"
AKRX,AKRX:UW,BBG000BBJN38,"Notable Tuesday Option Activity: MNST, IDCC, AKRX",2016-05-17 20:47:30 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/m9kkJ75blRE/notable-tuesday-option-activity-mnst-idcc-akrx-cm622422,"Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Monster Beverage Corp (Symbol MNST), where a total volume of 8,763 contracts has been traded thus far today, a contract volume"
AKRX,AKRX:UW,BBG000BBJN38,Akorn Provides First Quarter 2016 Results,2016-05-16 21:12:06 +0000,http://www.publicnow.com/view/A062B669C3E65EBF483F6091D67E8363951C3114,"[at noodls] - - Q1 2016 GAAP Revenue of $268 million - - GAAP EPS of $0.34; Adjusted Q1 2016 EPS of $0.54 - - Conference Call and Webcast to Be Held May 17, 2016 at 10:00 a.m. EDT - LAKE FOREST, Ill., May 16, 2016 (GLOBE ..."
AKRX,AKRX:UW,BBG000BBJN38,Akorn meets 1Q profit forecasts,2016-05-16 21:03:33 +0000,http://sg.finance.yahoo.com/news/akorn-meets-1q-profit-forecasts-210333663.html,Akorn meets 1Q profit forecasts
AKRX,AKRX:UW,BBG000BBJN38,Mid-Afternoon Market Update: U.S. Stocks Turn Higher; Endo International Shares Plunge,2016-05-15 05:34:14 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-JjXP5X4UdQ/mid-afternoon-market-update-us-stocks-turn-higher-endo-international-shares-plunge-cm617812,"Toward the end of trading Friday, the Dow traded up 0.36 percent to 17,724.30 while the NASDAQ climbed 0.17 percent to 4,725.34. The S&P also rose, gaining 0.24 percent to 2,055.59.  Leading and Lagging Sectors"
AKRX,AKRX:UW,BBG000BBJN38,Mid-Morning Market Update: Markets Edge Higher; Tyson Foods Tops Q2 Estimates,2016-05-15 05:34:11 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/dN5vmEVVVb0/mid-morning-market-update-markets-edge-higher-tyson-foods-tops-q2-estimates-cm618318,"Following the market opening Monday, the Dow traded up 0.14 percent to 17,765.08 while the NASDAQ climbed 0.34 percent to 4,752.35. The S&P also rose, gaining 0.20 percent to 2,061.15.  Leading and Lagging Sectors  On"
AKRX,AKRX:UW,BBG000BBJN38,Teva's (TEVA) Stock Gains on Q1 Earnings & Revenue Beat,2016-05-10 13:19:25 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/54bXxsBoccA/tevas-teva-stock-gains-on-q1-earnings-revenue-beat-cm618631,"Teva Pharmaceutical Industries Ltd.'sTEVA shares were up more than 5% with the company announcing better than expected first quarter 2016 results. While earnings came in at $1.20 per share, well above the Zacks Consensus Estimate of $1.13, revenues were"
AKRX,AKRX:UW,BBG000BBJN38,Akorn Completes 2014 Financial Statement Restatement and Reports Audited 2015 and Restated 2014 Results,2016-05-10 11:08:11 +0000,http://www.publicnow.com/view/3BFF6A5D1A6E2F48554229BCEA3FA56861A71142,"[at noodls] - - Sets Date for 2016 Annual Meeting - Affirms 2016 Net Revenue and Earnings per Share Guidance LAKE FOREST, Ill., May 10, 2016 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq:AKRX), a leading specialty generic ..."
AKRX,AKRX:UW,BBG000BBJN38,"Akorn Outlines Timeline for 2015 Form 10-K Filing, First Quarter 2016 Form 10-Q Filing and Investor Conference Calls",2016-05-06 19:04:03 +0000,http://www.publicnow.com/view/A55FE33458836D51F169770556ABA7267ACDC224,"[at noodls] - LAKE FOREST, Ill., May 06, 2016 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq:AKRX), a leading specialty generic pharmaceutical company, today announced the target dates for upcoming filings and press releases. ..."
AKRX,AKRX:UW,BBG000BBJN38,"Friday's ETF Movers: GDXJ, IHE",2016-05-06 18:27:34 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/HTXjyrIXM1k/fridays-etf-movers-gdxj-ihe-cm617752,"In trading on Friday, the Junior Gold Miners ETF ( GDXJ ) is outperforming other ETFs, up about 5.6% on the day. Components of that ETF showing particular strength include shares of Silvercorp Metals (SVM.CA), up about 11.5% and"
AKRX,AKRX:UW,BBG000BBJN38,Oversold Conditions For Akorn (AKRX),2016-05-06 17:32:03 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/mH9VNlYLe-U/oversold-conditions-for-akorn-akrx-cm617714,"Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis"
AKRX,AKRX:UW,BBG000BBJN38,First Week of AKRX December 16th Options Trading,2016-04-21 16:24:12 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/IPZeaoVBEPc/first-week-of-akrx-december-16th-options-trading-cm609514,"Investors in Akorn Inc (Symbol AKRX) saw new options begin trading this week, for the December 16th expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time"
AKRX,AKRX:UW,BBG000BBJN38,Relypsa Soars 67% in Thursday Trading on Buyout Rumors,2016-04-08 16:05:38 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/4lMmWTg0ywE/relypsa-soars-67-in-thursday-trading-on-buyout-rumors-cm603707,"Biopharma company, Relypsa, Inc.'sRLYP shares shot up a whopping 67% yesterday on acquisition rumors. According to a Reuters article, Relypsa is exploring the possibility of a potential sale following interest from prospective buyers. While the company is rumored to"
AKRX,AKRX:UW,BBG000BBJN38,Akorn Provides Preliminary Unaudited Full Year 2015 Financial Results and Issues 2016 Financial Guidance,2016-03-22 11:20:38 +0000,http://www.publicnow.com/view/B906F9E75202D38BA1E43826BC34F30979CC12EB,[at noodls] - - Preliminary 2015 GAAP Revenue of $985 Million - - Preliminary 2015 GAAP EPS of $1.14; Preliminary Adjusted 2015 EPS of $1.93 - - GAAP Revenue of $1.06 - $1.08 Billion Expected in 2016 - - Adjusted EPS ...
AKRX,AKRX:UW,BBG000BBJN38,Akorn Announces Conclusion of Audit Committee Independent Investigation,2016-01-27 22:05:03 +0000,http://www.publicnow.com/view/372A3DADF45D5002A55191FD856D31C462AB991B,"[at noodls] - , (GLOBE NEWSWIRE) -- (Nasdaq:AKRX) today announced that the Audit Committee of Akorn's Board of Directors concluded its independent investigation into Akorn's accounting and other matters. ... This is ..."
AKRX,AKRX:UW,BBG000BBJN38,Akorn Appoints Greg Lawless as Chief Human Resources Officer,2016-01-21 12:25:14 +0000,http://www.noodls.com/view/863B4202CAEB2D9A25CF06228CCE98450CFD1F77,"[at noodls] - , (GLOBE NEWSWIRE) -- (Nasdaq:AKRX), a leading specialty generic pharmaceutical company, today announced that joined as Chief Human Resources Officer on . ... This is an abstract of the original noodl. ..."
AKRX,AKRX:UW,BBG000BBJN38,Akorn Provides Material Updates,2016-01-14 22:49:20 +0000,http://www.noodls.com/view/500CB5D00E71BA9D73FE6554E4E6644CB2CB4B30,"[at noodls] - - Engaged as Independent Registered Public Accounting Firm - - Nasdaq Listing Extension Granted Through - - Conference Call Scheduled for on - , (GLOBE NEWSWIRE) -- (Nasdaq:AKRX) today announced that engaged ..."
AKRX,AKRX:UW,BBG000BBJN38,Akorn Receives Additional Delinquency Notice from Nasdaq,2015-11-13 23:26:01 +0000,http://www.noodls.com/view/6E9F1AF058068C6D041B5C6A1DD0E4BFDC0BB950,"[at noodls] - Notice for Third Quarter 2015 Expected Due to Akorn's Ongoing Restatement Process LAKE FOREST, Ill., Nov. 13, 2015 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq:AKRX) today announced that, as expected, it has ..."
AKRX,AKRX:UW,BBG000BBJN38,Akorn Provides Business and Financial Guidance Update,2015-11-04 21:38:15 +0000,http://www.noodls.com/view/BCDB67B52F1E4A5C253BEC8CCAA802EFCDF8C6F8,"[at noodls] - LAKE FOREST, Ill., Nov. 4, 2015 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq:AKRX), a leading specialty generic pharmaceutical company, today provided an update on the company's ongoing restatement process ..."
AKRX,AKRX:UW,BBG000BBJN38,Akorn Appoints Duane A. Portwood as Chief Financial Officer,2015-10-13 21:08:08 +0000,http://www.noodls.com/view/26C2FE31A593FAF2F78A87C042C560FCC80B1EE3,[at noodls] - Akorn Appoints Duane A. Portwood as Chief Financial Officer
AKRX,AKRX:UW,BBG000BBJN38,Akorn Launches Doxercalciferol Injection,2015-09-21 11:05:12 +0000,http://www.noodls.com/view/41B1029CB3B50491C894C92841D8B540B809B680,"[at noodls] - LAKE FOREST, Ill., Sept. 21, 2015 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq:AKRX), a leading specialty pharmaceutical company, today announced that it has launched Doxercalciferol Injection Solution, 4 mcg/2 ..."
AKRX,AKRX:UW,BBG000BBJN38,Akorn Launches Two Additional Promethazine Syrup Formulations,2015-09-17 11:31:10 +0000,http://www.noodls.com/view/AB30A717DA4BE49D277DE6CD2A3EF0D9C502D659,"[at noodls] - LAKE FOREST, Ill., Sept. 17, 2015 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq:AKRX), a leading specialty pharmaceutical company, today announced that it has launched Promethazine Hydrochloride and Phenylephrine ..."
AKRX,AKRX:UW,BBG000BBJN38,Analysts expect more tie-ups in generic drug business,2015-07-27 20:43:30 +0000,http://sg.finance.yahoo.com/news/analysts-expect-more-tie-ups-185522109.html,Analysts expect more tie-ups in generic drug business
AKRX,AKRX:UW,BBG000BBJN38,Pharmaceutical firm wants lethal injection drugs returned,2015-05-06 20:42:04 +0000,http://sg.finance.yahoo.com/news/pharmaceutical-firm-wants-lethal-injection-172738049.html,Pharmaceutical firm wants lethal injection drugs returned
AKRX,AKRX:UW,BBG000BBJN38,Manufacturer asks Oklahoma to return any execution drugs,2015-05-01 02:17:17 +0000,http://sg.finance.yahoo.com/news/manufacturer-asks-oklahoma-return-execution-204034951.html,Manufacturer asks Oklahoma to return any execution drugs
AKRX,AKRX:UW,BBG000BBJN38,Akorn shares fall on financial restatement plans,2015-04-27 18:10:02 +0000,http://sg.finance.yahoo.com/news/akorn-shares-fall-financial-restatement-181002872.html,Akorn shares fall on financial restatement plans
AKRX,AKRX:UW,BBG000BBJN38,Akorn climbs on 4th-quarter totals and strong 2015 outlook,2015-02-26 18:02:15 +0000,http://sg.finance.yahoo.com/news/akorn-climbs-4th-quarter-totals-180215764.html,Akorn climbs on 4th-quarter totals and strong 2015 outlook
AKRX,AKRX:UW,BBG000BBJN38,Akorn beats Street 4Q forecasts,2015-02-26 14:40:04 +0000,http://sg.finance.yahoo.com/news/akorn-beats-street-4q-forecasts-144004562.html,Akorn beats Street 4Q forecasts
AKRX,AKRX:UW,BBG000BBJN38,Akorn reports 3Q loss,2014-11-06 12:51:53 +0000,http://sg.finance.yahoo.com/news/akorn-reports-3q-loss-125153207--finance.html,Akorn reports 3Q loss
